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 14	  
The integration of chromatin regulation into the gene regulatory networks that 15	  
progressively transform endocardial cushions into highly structured valves is poorly 16	  
understood. To investigate contributions of chromatin remodeling to valve development, 17	  
we use two endocardial Cre lines to conditionally delete floxed Brg1, the core subunit of 18	  
the Brg1-associated factor complex. In an early-deleting Tie2:Cre model, loss of Brg1 19	  
disrupts endocardial-mesenchymal transformation (EMT) in both the proximal outflow 20	  
tract (pOFT) and atrioventricular canal (AVC) cushions. EMT appears to initiate 21	  
normally in the absence of Brg1, but endocardial cells fail to switch from an epithelial to 22	  
mesenchymal gene expression program. In a later-deleting Nfatc1Cre model, Brg1- 23	  
deficient mice develop thickened, malpatterned and frequently bicuspid semilunar valves 24	  
while showing normal AVC-derived valves. Fate mapping experiments demonstrate that 25	  
the enlarged semilunar valves result from an expansion of non-Nfatc1Cre-lineage 26	  
mesenchyme. Paradoxically, until E14.5, these same embryos have smaller semilunar 27	  
valves, originating from a moderate deficiency of pOFT EMT. Depletion of this 28	  
mesenchyme sub-population precludes formation of the valves’ base and hinge regions 29	  
and disrupts growth regulatory networks, causing the valves to progress to a diseased 30	  
	   v 
state. RNA-seq of E14.5 Nfatc1Cre;Brg1F/F cardiac cushions identifies novel transcripts 1	  
that may coordinate cellular interactions that direct growth and patterning stages of 2	  
semilunar valve development. We propose that early disruption of EMT in the pOFT is 3	  
sufficient to trigger secondary responses that culminate in commonly observed valve 4	  
phenotypes in both mouse genetic models and human disease.  5	  
This dissertation includes previously published and unpublished co-authored 6	  
material.  7	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CHAPTER I  
 
INTRODUCTION 
 
 
Congenital heart defects (CHD) are the number one cause of deaths in infants and 
congenital valve disease (CVD) affects nearly 2% of the world’s population. The high 
incidence of these congenital diseases emphasizes the need to understand the cause of 
these common birth defects (Go et al. 2013). Often semilunar valve (SLV) disease 
originates as a congenital defect and is characterized by dramatically overgrown and 
myxomatous aortic/pulmonic valves (Stephens et al. 2012).  
 
Mammalian valve development is a complex developmental process that initiates 
with the formation of primitive endocardial cushions that subsequently mature into 
elongated and thin valves. Cardiac cushions are temporally and spatially restricted 
‘swellings’ between the endocardium and myocardium with a secreted proteoglycan-rich 
substance called cardiac jelly (Eisenberg and Markwald 1995). An endothelial-to-
mesenchymal transformation (EMT) originates from the endocardium to populate the 
proximal-outflow tract (pOFT) and atrioventricular canal (AVC) cardiac cushions (Krug 
et al. 1987; Eisenberg and Markwald 1995). Beginning at embryonic day 9.5 (E9.5), a 
defined subset of endocardial cells undergo EMT to delaminate from the endocardium, 
differentiate into a mesenchymal cell and migrate into the extracellular matrix within 
both the AVC and pOFT cushions. This process requires several signaling molecules to 
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initiate and reinforce the EMT process. Misexpression of growth factor ligands inhibits 
EMT and similarly, loss of cardiac transcription factors and/or Notch signaling 
components leads to severe EMT defects on all cardiac cushions (Akhurst et al. 1990; 
Potts et al. 1991; Ramsdell and Markwald 1997; Rivera-Feliciano et al. 2006; 
Timmerman et al. 2004; Wang et al. 2013). Extensive research has described early 
endocardial cushion formation, but we remain perplexed about the molecular regulation 
of endocardial cushion maturation and remodeling stages of valve development.  
 
The outflow tract has two distinct sets of endocardial cushions that contain 
mesenchyme of multiple cellular origins. The proximal outflow tract (pOFT) cushion is 
most adjacent to the newly looped heart and contributes to semilunar valves and septation 
of the ventricles. The pOFT is primarily made up of endocardial-derived mesenchyme. 
The distal outflow tract (dOFT) is situated farthest from the developing ventricles. The 
dOFT forms semilunar valves and provides material for septation of the outflow tract into 
the pulmonary and aortic arteries. Permanent lineage labeling studies have shown that 
dOFT mesenchyme primarily originates from cardiac neural crest and possibly second 
heart field (Kirby et al. 1983; Waldo et al. 1998; Jiang et al. 2000; Engleka et al. 2012; 
Sizarov et al. 2012). By E13.5, the cardiac valves begin to elongate and refine into thin 
cusps through the organization of extracellular matrix (ECM) into distinct regions. It is of 
considerable debate how the endocardial cushions mature into a valve that can withstand 
a lifetime of mechanical force to allow for proper blood flow. By late embryonic 
development, ECM begins to stratify into three distinguishable layers (Hinton et al. 2006). 
Collagens, proteoglycans and elastin become localized within the fibrosa, spongiosa and 
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ventricularis layers respectively, to generate the proper stiffness and flexibility of the 
individual cusps that retain form to regulate blood flow over the span of a lifetime (Gross 
and Kugel 1931; Broom 1978; Votteler et al. 2013). The extracellular matrix proteins are 
specifically distributed within the valve and their localization is often found perturbed in 
malformed and myxomatous valves (Wirrig et al. 2007; Tkatchenko et al. 2009; Hinton et 
al. 2010; Iwamoto et al. 2010; Kern et al. 2010; Dupuis et al. 2011).  
 
Equally important as the transverse organization of the semilunar valves, is the 
medial-to-lateral patterning. The aortic and pulmonic valves are made up of three cusps. 
Each cusp can be considered as a shallow cup partially fastened within a cylindrical 
structure. All three of the aortic and pulmonic cusps contain a base region that fosters the 
connection to the smooth muscle and/or myocardium. This base region provides the 
rigidity and stiffness for the cusp and exhibits high expression of Tenascin C. The distal 
region of the cusps requires flexibility for opening and closing and display high 
expression of Versican and Periostin. The smooth muscle regions between the cusps are 
called interleaflet regions that lend support to the valve cusps. Together, the multi-
dimensional organization of the semilunar valve interstitium suggests that proper 
formation is governed a complex set of developmental signaling cues. What is known 
about semilunar valve defects are primarily from studies of human diseased valves, 
where the disease has manifested to a myxomatous state. It is difficult to distinguish the 
initiation from the progression of semilunar valve disease (BAVD) and the former being 
the primary interest to genetic studies and the latter for therapeutic approaches. While a 
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number of genetic variants and disruptions have been associated with semilunar valve 
disease, an understanding of the role of chromatin regulators has yet to be elucidated.  
 
Multi-subunit remodeling complexes that facilitate the activation and repression 
of genes through ATP-dependent nucleosome repositioning and replacement provide one 
mechanism of chromatin regulation. The SWI/SNF, or Brg1-associated factor (BAF) 
complex is a widely studied chromatin remodeling complex that is essential for 
development, such that complete mouse knock-out models are peri-implantation lethal 
(Bultman et al. 2000). Brg1 is the core ATPase subunit of the BAF complex and loss of 
Brg1 renders the BAF complex inactive (Kadoch and Crabtree 2013). The SWI/SNF 
complex is essential during mammalian heart development and studies have shown its 
importance in cardiomyocyte specification and ventricular trabeculation (Lickert et al. 
2004; Stankunas et al. 2008; Takeuchi et al. 2011). Secondly, Brg1 is strongly expressed 
in a number of cell types, specifically in endocardial cells of the developing cardiac 
valves, which implicates a possible role for Brg1 during valvulogenesis. 
 
 The material presented in Chapter II describes a new mouse model for a common 
congenital heart defect, which has been accepted and recently published at 
Developmental Biology (online). Nearly all of the data presented in Chapter II was 
obtained and analyzed by myself, whereas Chapter III contains data (in the form of 
figures) obtained by myself and Vidusha Devasthali.  
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CHAPTER II 
 
ENDOCARDIAL BRG1 DISRUPTION ILLUSTRATES THE DEVELOPMENTAL 
ORIGINS OF SEMILUNAR VALVE DISEASE 
 
 
 
JOURNAL STYLE INFORMATION 
Brynn N. Akerberg, Maithri L. Sarangam, Kryn Stankunas. Reproduced with permission 
from Developmental Biology 2015. Copyright 2015. 
 
AUTHOR CONTRIBUTIONS 
I performed the experiments presented in this manuscript, with the exception of the 3-
dimensional renderings of the E16.5 aortic valves. This data, presented in Fig. 1I, J and 
Fig. S5, was obtained and analyzed by an undergraduate researcher, Maithri Sarangam. 
Dr. Stankunas and I designed the experiments, prepared and wrote the manuscript.  
 
INTRODUCTION 
Congenital valve defects affect at least 2% of humans, a remarkable frequency that 
underlines the urgent need to understand their etiology (Hoffman and Kaplan 2002; Siu 
and Silversides 2010; Go et al. 2013). Frequently, developmentally abnormal valves do 
not progress to a pathologic state until late adulthood. For example, many cases of adult 
aortic valve disease characterized by thickened and myxomatous valve cusps display 
bicuspid rather than tricuspid arrangements originating from fusions during development 
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(Angelini et al. 1989; Roberts and Ko 2005). The rationale design of diagnostics and 
therapeutics therefore must distinguish between disrupted developmental processes, and 
their genetic and environmental influences, that trigger valve defects from mechanisms 
that drive the progression of an anatomically abnormal valve to a disease state. 
 
Valvulogenesis is a dynamic and multistep process that transforms primitive endocardial 
cushions (ECs) into highly patterned valves with thin, elongated leaflets or cusps. ECs 
form at discrete sites of the looping heart tube by the local secretion of a specialized 
extracellular matrix called the cardiac jelly. The mesenchyme of atrioventricular canal 
ECs, which generate the mitral and tricuspid valves, originates from an endothelial-to-
mesenchymal transition (EMT) of a subset of overlying endocardial cells. The outflow 
tract contains two pairs of neighboring ECs that together will form the semilunar valves. 
The proximal outflow tract (pOFT) cushions are primarily populated by EMT-derived 
mesenchyme. In contrast, the distal outflow tract (dOFT) cushion mesenchyme is largely 
derived from invading cardiac neural crest cells (NCCs) (Kirby et al. 1983; Waldo et al. 
1998; Jiang et al. 2000). Additional cell populations, possibly of second heart field (SHF) 
origin, may contribute additional mesenchyme to the OFT cushions (Engleka et al. 2012; 
Sizarov et al. 2012).  
 
EMT begins at embryonic day 9.5 (E9.5) in the AVC and soon after in the pOFT 
(Camenisch et al. 2002). Signaling factors, notably TGF-beta superfamily and Notch 
proteins, direct EMT by promoting gene expression program changes that transition 
endocardial cells from an interconnected epithelial to invasive mesenchymal state 
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(Ramsdell and Markwald 1997; Timmerman et al. 2004; Fischer et al. 2007; Venkatesh et 
al. 2008; Luna-Zurita et al. 2010; Chang et al. 2011; Wang et al. 2013). Deficient 
mesenchyme production, including when EMT is disrupted, impedes subsequent steps of 
valve development and leads to congenitally abnormal valves. A connection between 
EMT disruption and semilunar valve disease is suggested by Notch1 being one of the few 
identified human aortic valve disease genes (Garg et al. 2005), although Notch signaling 
may also have later roles in valve development or homeostasis (Hofmann et al. 2012; 
Theodoris et al. 2015). 
 
After EMT, the paired OFT ECs undergo a complex rearrangement to form two sets of 
symmetric tricuspid semilunar valves. By E13.5, the ECs meet and rearrange 
concomitantly with OFT septation to form separate pulmonic and aortic valves. The three 
cusps of each semilunar valve elongate and refine into thin tissues that will distend to 
meet and form a tight seal but have the flexibility to promptly open under pressure. 
Through postnatal development, the valve interstitium becomes stratified into layers of 
distinct extracellular matrix (ECM) composition to confer appropriate stiffness/flexibility 
across the cusps’ short axis (Gross and Kugel 1931; Broom 1978; Hinton et al. 2006). 
Genetic loss or disruption of several extracellular proteins, such as Versican (Vcan) and 
Periostin (Postn), or their regulators, notably Adamts-family matrix proteases, produce 
valve defects (Tkatchenko et al. 2009; Kern et al. 2010; Dupuis et al. 2011; Cheek et al. 
2012).  
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The semilunar valves are also patterned along their proximal-to-distal (long) axis. Each 
cusp of both aortic and pulmonic valves can be considered as a shallow bisected cup 
fastened within a cylindrical structure (Fig. S1A-B; see Appendix for all Supplemental 
Figures). The cusps’ base region that connects them to underlying muscle is enriched 
with Tenascin C (Tnc), which helps confer tissue rigidity (Zhang et al. 1993; Satta et al. 
2002; Hinton et al. 2006). In contrast, the flexible distal part of the cusps express high 
levels of Vcan and Postn (Kruzynska-Frejtag et al. 2001; Norris et al. 2008; Snider et al. 
2008; Kern et al. 2010). The junction between the stiff base and flexible distal regions is 
commonly termed the hinge. The multi-dimensional organization of semilunar valve 
interstitium suggests that valve patterning requires a highly coordinated series of events 
that act over an extended period of development. Any of these steps could be perturbed to 
cause formation of a congenitally abnormal valve. 
 
Human genetics and model organism studies, largely in mice, highlight disrupted 
regulatory pathways that coalesce on transcriptional changes as primary sources of SLV 
defects. For example, disrupted Notch signaling produces bicuspid aortic valve (BAV) in 
both mice and humans (Garg et al. 2005; Jain et al. 2011; Bosse et al. 2013). Additional 
mouse models of semilunar valve disease implicate Gata5 and Pax3 transcription factors 
and transcriptional effectors of Tgf-β family signaling (Jain et al. 2011; Laforest et al. 
2011; Thomas et al. 2012; Dupuis et al. 2013). The molecular activities of these 
transcription factors, including an understanding of how they function within a 
chromatinized landscape to direct specific responses, are poorly understood. A role for 
chromatin regulation in human SLV disease is supported by the high frequency of de 
	   9 
novo variants in histone modifying genes in congenital heart disease (Zaidi et al. 2013). 
Further the sporadic inheritance patterns in afflicted families (Clementi et al. 1996; 
Huntington et al. 1997)  suggest epigenetic influences that modify penetrance and/or 
expressivity of disease-causing alleles. 
 
The Brg1-associated factor (BAF) chromatin remodeling complex facilitates activation 
and repression of genes by ATP-dependent nucleosome repositioning and/or replacement. 
The core ATPase subunit is predominantly provided by Brg1; in most cases, loss of Brg1 
alone inactivates the BAF complex (Kadoch et al. 2013). Coordinately, Brg1-null mice 
are peri-implantation lethal (Bultman et al. 2000). The BAF complex has been implicated 
in multiple steps of heart development and disease, including cardiac specification and 
hypertrophy (Lickert et al. 2004; Hang et al. 2010; Takeuchi et al. 2011). Further, Brg1 is 
required in endocardial cells to maintain the microenvironment required for the initiation 
of cardiac trabeculation (Stankunas et al. 2008). Brg1 expression in endocardial and 
mesenchymal cells of the developing valves suggests additional roles for endocardial 
lineage BAF complexes during valvulogenesis. 
 
Here, we disrupt endocardial-lineage Brg1 in mice to demonstrate that the BAF 
chromatin remodeling complex is essential for semilunar valve development. Endocardial 
Brg1-deficient embryos develop thickened aortic and pulmonic valves that frequently are 
bicuspid and progress to a myxomatous, disease-like state. We map the origins of these 
defects to a partial disruption of pOFT EMT, a process an earlier deletion of endocardial 
Brg1 shows the BAF complex is required for in both the pOFT and AVC. Developing 
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semilunar valves compensate for the deficiency of EMT-derived mesenchyme, but the 
responding mesenchymal populations are insufficient to fully pattern a complex, multi-
origin semilunar valve interstitium. Therefore, an initial deficiency of pOFT EMT can 
trigger secondary responses that culminate in semilunar valve disease. By RNA-seq 
analysis of the Brg1-deficient valves, we additionally identify and characterize the 
expression of novel transcripts that may promote growth and patterning of semilunar 
valves and/or serve as biomarkers of a diseased state. 
 
MATERIALS AND METHODS 
Mice 
All mouse husbandry and procedures were approved and monitored by the University of 
Oregon’s Institutional Animal Care and Use Committee. Transgenic lines are described 
in Supplemental Materials.  
 
Tissue processing and sectioning 
Mouse embryos or dissected adult hearts were fixed overnight in 4% PFA/PBS at 4°C. 
Fixed tissue was washed thoroughly and then equilibrated overnight with PBS at 4°C. 
Samples were dehydrated through a graded ethanol series and cleared with xylenes prior 
to paraffin embedding. 7 mm paraffin sections were transferred to microscope slides for 
either histological or fluorescent antibody staining. Cryosections were used for RNA in 
situ hybridizations and occasional antibody staining (see Supplementary Materials). For 
cryosections, embryos were fixed as described, washed thoroughly with PBS, 
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equilibrated in 30% sucrose overnight at 4°C, embedded in OCT (Tissue-Tek), and 
sectioned (16 µm). 
 
Histology 
Hematoxylin and eosin (H&E) staining used paraffin sections and conventional reagents 
and methodology (Ricca Chemical Company). Masson’s Trichrome staining on paraffin 
sections used a reagent kit following manufacturer’s instructions (Electron Microscopy 
Sciences). Von Kossa stained paraffin sections were counterstained with Alcian Blue (pH 
2.5) and Nuclear Fast Red (Vector Laboratories). 
 
Immunostaining 
Paraffin-sectioned tissue on slides was de-paraffinized and rehydrated to distilled water 
using a graded series of ethanol washes. Antigen retrieval was performed as described in 
Supplemental Materials. The slides were blocked with M.O.M protein diluent (Vector 
Laboratories) or 10% normal goat serum (NGS) in PBS for 1 hour at RT and then stained 
overnight with primary antibodies diluted in blocking buffer (sources and dilutions in 
Supplemental Materials). Alexa dye-conjugated fluorescent secondary antibodies (Life 
Technologies) were used to detect signal. Nuclei were stained with Hoechst (Life 
Technologies). Slides were mounted with Vectashield (Vector Laboratories). 
Immunofluorescent images were acquired using a widefield microscope or an Olympus 
FV1000 laser-scanning confocal microscope. Confocal images shown are average 
intensity projections of image stacks. 
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RNA In situ hybridization 
In situ hybridizations were performed using cryosections (16 µm) except for Nptx1, 
which used paraffin sections (7 µm), as described (Stewart et al. 2014). Briefly, frozen 
sections were washed with PBS and PBST prior to Proteinase K treatment. Alternatively, 
paraffin sectioned tissue was first de-paraffinized and rehydrated. Sections were post-
fixed with 4% PFA, washed, and incubated with pre-hybridization buffer at 65°C for 4 
hours. Digoxigenin (DIG)-labeled RNA probes (see Supplemental Materials) were 
hybridized overnight at 65°C. Following multiple washes, the tissue was blocked with 
1% Roche blocking buffer (Roche) and then stained with alkaline phosphatase-
conjugated anti-DIG antibody (Roche) overnight at 4°C. The signal was developed after 
extensive TBST washes using BCIP/NBT (Promega). Tissue was counterstained with 
Nuclear Fast Red (Vector Laboratories) before being processed for mounting with 
Permount (Electron Microscopy Sciences). 
 
Valve morphometrics 
Optimally matched H&E stained sections for each studied valve of wildtype and 
littermate Nfatc1Cre;Brg1F/F embryos were imaged for area and distance measurements 
using ImageJ  (NIH). Length-to-width ratios were determined as described previously 
(Stankunas et al. 2010). Cell numbers were counted manually. Data from multiple litters 
was combined by normalizing values to the mean of wildtype embryos within each letter. 
Statistical significance was determined using two-tailed Student’s t-tests. 
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Valve 3D reconstructions 
7 mm serial paraffin sections covering the entire E16.5 aortic valve were collected, H&E 
stained and imaged. All images (slices in stack) were imported into ImageJ (NIH) and 
aligned manually to neighboring valve sections using the Trakem2 plugin (Cardona et al. 
2012). An ‘area list’ for each cusp (LCC, RCC, NCC) was generated manually for every 
layer before being merged across layers to establish 3-D shapes. Adjustments made for 
the z-space and thickness were standardized for a given litter to allow a direct comparison 
between wildtype and Nfatc1Cre;Brg1F/F aortic valves. A two-tailed Student’s t-test 
comparing total aortic valve volumes (all cusps) between wildtype and Nfatc1Cre;Brg1F/F 
embryos used data normalized to the mean of the wildtype aortic valve volumes within 
each litter. 
 
In vivo EdU labeling and proliferation assays 
Pregnant females were IP injected with 50 mg/kg of 5-ethynyl-2´-deoxyuridine (EdU; 
Life Technologies) 2-3 hours before embryos were harvested. Paraffin sections were 
prepared for staining as described. For combined lineage tracing and EdU proliferation 
studies, slides were incubated for 10’ in a pressure cooker with DAKO antigen retrieval 
solution (DAKO). The slides were blocked for one hour with 10% NGS/PBS after 
antigen retrieval followed by a Click-iT reaction (Life Technologies). Subsequently, 
slides were washed 6X 10’ with PBS before proceeding with anti-GFP antibody staining 
as described in the Supplemental Materials. 
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EMT explant assays 
Collagen gel EMT explant assays using dissected E10.0 outflow tract tissue were 
performed as described (Xiong et al. 2011). 1 mg/ml rat tail collagen I (BD Biosciences) 
matrices were supplemented with 5 mg/ml doxycycline to induce the TRE:H2BGFP 
reporter used for fluorescent lineage tracing. Explants were incubated at 37°C in 5% 
O2/5% CO2 for 48 hours before brightfield and fluorescent imaging on an inverted Nikon 
Eclipse Ti widefield microscope. 
 
Quantitative RT-PCR 
qRT-PCR was performed using KAPA SYBR FAST qPCR Master Mix (Kapa 
Biosystems) and cDNA synthesized using SuperScript III (Life Technologies) from 
Trizol-isolated RNA prepared from dissected valve regions. Relative mRNA expression 
was normalized using a control transcript (HPRT) to calculate ΔCTs (threshold cycles). 
Expression levels between wildtype and Nfatc1Cre;Brg1F/F hearts were compared using a 
ΔΔCT approach. ΔCT values were used for two-tailed Student’s t-tests with a Bonferroni 
correction for multiple comparisons to determine statistical significance. Primer 
sequences are in Supplemental Materials. 
 
Illumina RNA sequencing  
The valve-containing region of E14.5 hearts was dissected under a fluorescent 
stereomicroscope using the guide of an endocardial-lineage nuclear GFP reporter (see 
Supplemental Materials). RNA was extracted using TRIzol (Life Technologies). RNA-
sequencing libraries were prepared from two sets of individual paired control and 
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littermate Nfatc1Cre;Brg1F/F embryos as described in Supplemental Materials. The 
bioinformatics workflow to determine differentially gene expression is also presented 
therein.  
 
RESULTS 
Endocardial Brg1 is required for semilunar valve development 
Prior studies of Brg1 roles in the developing endocardium showed that the BAF complex 
is required at embryonic day E9.5 to transcriptionally maintain a microenvironment that 
supports ventricular trabeculation (Stankunas et al. 2008). Persistent endocardial Brg1 
expression throughout the embryonic heart suggested additional endocardial BAF 
complex functions in other heart regions or during later steps of cardiogenesis. The 
previous use of the Tie2:Cre line to conditionally delete floxed Brg1 alleles precluded 
studying later roles due to lethality arising from hematopoietic and yolk sac vasculature 
defects in Tie2:Cre;Brg1F/F embryos (Stankunas et al. 2008). Therefore, we used the 
Nfatc1Cre line that expresses Cre from the Nfatc1 locus to specifically remove Brg1 from 
endocardial but not endothelial or hematopoietic cells (Wu et al. 2012). 
 
Nfatc1Cre;Brg1F/F mice rarely survived to adulthood, accounting for 3% rather than an 
expected 25% of animals generated from Nfatc1Cre;Brg1F/+ X Brg1F/F  intercrosses (Fig. 
S2A, F). A decreased fraction of viable Nfatc1Cre;Brg1F/F embryos was first observed at 
E16.5 with few animals surviving after birth, demonstrating late embryonic or perinatal 
lethality. Hearts from the rare viable postnatal day 0 (P0) Nfatc1Cre;Brg1F/F were grossly 
larger and histologically had a thickened compact myocardium, possibly reflecting 
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endocardial BAF complex roles in trabecular development (Fig. S2B-E). The coronary 
artery network was reduced (Fig. S2G-J), consistent with known BAF complex functions 
in vasculogenesis (Griffin et al. 2008; Stankunas et al. 2008) and Nfatc1Cre-driven 
recombination in coronary vessel endothelium of endocardial origin (Wu et al. 2012). 
These defects likely contributed to the perinatal lethality. In addition to these phenotypes, 
hearts from Nfatc1Cre;Brg1F/F newborn mice had histologically thickened aortic and 
pulmonic valves (Fig. S2K-P).  
 
We examined if the semilunar valve defects seen in Nfatc1Cre;Brg1F/F mice manifested 
earlier in development by H&E staining of sectioned E16.5 embryos. The semilunar 
valve cusps of Nfatc1Cre;Brg1F/F embryos were strikingly thickened and poorly elongated. 
The thinner “hinge” region that demarcates the boundary between the distal and basal 
regions of each cusp of both aortic and pulmonic valves was absent (Fig. 1A-B, D-E). In 
contrast, the mitral valve of Nfatc1Cre;Brg1F/F embryos was of normal size and 
organization (Fig. 1C, F). Quantitatively, the left and right cusps of the pulmonic valve 
from Nfatc1Cre;Brg1F/F E16.5 embryos had significantly decreased length:width ratios 
(0.998 vs. 0.581, P < 1.0E-4), were increased in area (0.998 vs. 1.76, P < 6.0E-3), and 
had a concordant modest increase in the number of interstitial cells per valve section (P < 
2.0E-3) (Fig. 1G). Semilunar valve defects in Nfatc1Cre;Brg1F/F embryos first became 
apparent at E14.5 as a decreased length:width ratio of the forming cusps although without 
a change in sectional area (Fig. S3B, F). E14.5 Nfatc1Cre;Brg1F/F embryos also 
occasionally had a small membranous ventricular septal defect, which usually resolved 
by E16.5 in surviving embryos (> 90%, n= 11)  (Fig. S3J-M). E16.5 Nfatc1Cre;Brg1F/F 
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mitral valve leaflets exhibited no significant change in morphology or cell number (Fig. 
1H), even though many mitral valve endocardial and mesenchymal cells had lost Brg1 
protein by E14.5 (Fig. S4A-F). The divergent effects on semilunar vs. atrioventricular 
canal valves suggested that the BAF complex has a unique role during semilunar valve 
development or that the idiosyncrasies of Nfatc1Cre deletion kinetics only perturbed 
Figure 1.  Endocardial-lineage Brg1 deficient embryos exhibit semilunar valve defects.  
(A-F) Hematoxylin and eosin (H&E) stained sections from E16.5 wildtype and 
Nfatc1Cre;Brg1F/F embryos showing indicated valves. Arrowheads mark the basal cusp regions 
of the semilunar valves. (G, H) Morphometric analyses of pulmonic and mitral valves from 
E16.5 wildtype and Nfatc1Cre;Brg1F/F embryos. Each data point represents one valve, with 
values normalized to the mean of the wildtype samples from individual litters. Asterisks 
indicate a significant difference (P < 0.05, Student’s two-tailed t-tests). (I, J) 3-dimensional 
rendering of serial sections of aortic valves from E16.5 wildtype and Nfatc1Cre;Brg1F/F 
littermate embryos. AoV: aortic valve; L/W: length-to-width; CC: mesenchymal cell count; NS, 
not statistically significant; LCC (blue): left coronary cusp; NCC (red): non-coronary cusp; 
RCC (yellow): right coronary cusp; LCC-NCC (purple): bicuspid fusion between left and non-
coronary cusps. Scale bars: 100 µm. 
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Brg1’s role in a common process in the developing outflow tract.  
 
3-D reconstruction of serial sections through the entire aortic valve of E16.5 
Nfatc1Cre;Brg1F/F and littermate embryos revealed that Nfatc1Cre;Brg1F/F aortic valves 
lacked the typical thin elongated cusps and extended aortic sinuses of wildtype littermates 
(Fig. S5A-D). However, Nfatc1Cre;Brg1F/F embryos retained coronary ostia with normal 
origins of the coronary arteries (Fig. S5E, F). Three of the six 3-D reconstructed 
Nfatc1Cre;Brg1F/F aortic valves were bicuspid. In each case, the bicuspid valve originated 
from a fusion between the left and non-coronary cusps (LCC-NCC), with residual 
individual cusp attachment points to the surrounding muscle. While several 
Nfatc1Cre;Brg1F/F aortic valves had larger volumes than those of paired littermates, this 
change was not statistically significant (Fig. S5G-R). Therefore, area changes seen by 
sectional analysis likely represented the bulbous shape of the valves rather than increased 
size, additionally highlighting how 2-D morphometric analyses of valve development can 
be misleading. Consistent with the valves having a normal volume, the pulmonic valve 
mesenchyme of E14.5/E15.5 Nfatc1Cre;Brg1F/F mice had no change in overall 
proliferation (measured by EdU incorporation and phospho-histone H3 staining, Fig. 
S6A-D, I-J) or apoptosis (measured by TUNEL and anti-cleaved caspase 3, Fig. S6E-H, 
K). Collectively, these results suggested that the semilunar valve defects in 
Nfatc1Cre;Brg1F/F mice primarily represent a patterning/morphogenesis defect rather than 
overall misregulated growth. 
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Bicuspid aortic valve (BAV) disease in endocardial Brg1 deficient mice 
The semilunar valve (SLV) defects present at E16.5 indicated that Nfatc1Cre;Brg1F/F mice 
would provide a mouse model of adult semilunar valve disease if not for the predominant 
perinatal lethality. Therefore, we conditionally deleted Brg1 with the less efficient parent 
line, Nfatc1Cre-PGK that retains the hygromycin-resistance cassette used for gene targeting 
(Wu et al. 2012). As described, the majority of Nfatc1Cre-PGK;Brg1F/F mice survived to 
adulthood, gradually losing their hair and whiskers due to a failure of hair follicle stem 
cell renewal (Xiong et al. 2013). While most Nfatc1Cre-PGK;Brg1F/F mice had a normal 
Figure 2. Endocardial-lineage Brg1 deficient adult mice develop aortic valve disease  
(A) Fraction of adult Nfatc1Cre-PGK;Brg1F/F or Nfatc1Cre;Brg1F/F mice with 1) 
thickened/myxomatous and/or 2) bicuspid aortic valve.  0/26 littermate control animals had 
abnormal aortic valves. (B, C) Whole mount anterior view of hearts from one year old (1yo) 
wildtype and Nfatc1Cre-PGK;Brg1F/F littermate mice. (D-G) H&E stained wildtype (D, E) and 
Nfatc1Cre-PGK;Brg1F/F (F, G) aortic valve sections. (H-K) Adult aortic valve sections stained 
using Masson’s Trichrome stain (collagen deposition in blue). Wildtype (H, I) and 
Nfatc1Cre;Brg1F/F (J, K) samples are shown. Black arrows mark mislocalized collagen. (L-O) 
Von Kossa and Alcian Blue (counterstained with Nuclear Fast Red) stained tissue sections from 
wildtype (L, M) and Nfatc1Cre;Brg1F/F (N, O) adult aortic valves. Black arrowheads indicate 
cartilaginous nodules. LCC: left coronary cusp; NCC: non-coronary cusp; RCC: right coronary 
cusp; LCC/RCC-NCC: bicuspid fusion between left/right and non-coronary cusps. Scale bars: 
100 µm.  
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lifespan (monitored for up to two years), their hearts were frequently enlarged with 
thickened ventricles (Fig. 2B, C, Fig. S7A-D). This cardiomyopathy could represent 
cardiac hypertrophy arising from pressure overload caused by a partial outflow tract 
obstruction. 
 
We examined hearts from adult Nfatc1Cre-PGK;Brg1F/F mice for semilunar valve defects 
(Fig. 2D-G) and found that Nfatc1Cre-PGK;Brg1F/F adult mice frequently had substantially 
thickened aortic valve cusps (21/26; 0/26 control littermates were affected). Nine had a 
bicuspid aortic valve (six LCC-NCC and three RCC-NCC), recapitulating the E16.5 
Nfatc1Cre;Brg1F/F embryonic phenotype. The pulmonic valves were similarly thickened, 
while the mitral valve appeared qualitatively normal (Fig. S7E-H). 
 
Trichrome staining indicated that Nfatc1Cre-PGK;Brg1F/F and rare surviving 
Nfatc1Cre;Brg1F/F mice aortic valves had myxomatous characteristics, with extensive 
proteoglycan-rich material throughout the valve and intermittent and dispersed collagen 
deposits rather than the typical enrichment of collagen along the arterial side of the cusps. 
Irregular chondrocyte-like cells with large nuclei and scattered small-nucleated cells were 
present, especially at the lateral edges of the cusps where they contact neighboring 
muscle (Fig. 2H-K). Similar histologic abnormalities are seen in human aortic valve 
disease and additional mouse models (Satta et al. 2002; Jackson et al. 2003; Kern et al. 
2010; Cheek et al. 2012; Hofmann et al. 2012; Krishnamurthy et al. 2012). We assessed 
if the valves became calcified, as can occur in human disease, using Von Kossa staining. 
Unexpectedly, we observed little or no change in calcification in adult Nfatc1Cre;Brg1F/F 
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aortic valves irrespective of age or severity of the valve thickening/disorganization 
phenotype (Fig. 2L-O). Collectively, Nfatc1Cre-PGK;Brg1F/F and rare surviving 
Nfatc1Cre;Brg1F/F mice establish a unique model of aortic valve disease that 1) has 
thickened, misorganized and myxomatous cusps, 2) forms bicuspid arrangements usually 
arising from LCC-NCC fusions and 3) does not become overtly calcified.	  	  
 
Endocardial Brg1 deficient semilunar valves exhibit a loss of interstitial 
organization 
We explored whether the ECM defects seen in adult Nfatc1Cre-PGK;Brg1F/F adult mice 
manifested developmentally or reflected disease-like progression by antibody staining for 
ECM proteins expressed in developing valves. Vcan, which is essential for valve 
maturation and enriched in the medial-distal region of semilunar valve cusps(Kern et al. 
2010; Dupuis et al. 2011), became diffusely localized in E16.5 Nfatc1Cre;Brg1F/F embryos 
with expression extending into the base regions (Fig. 3A-H). Postn expression, another 
ECM protein essential for valve maturation (Norris et al. 2008; Snider et al. 2009), was 
both expanded and increased in Nfatc1Cre;Brg1F/F semilunar valve cusps (Fig. 3I-L). In 
contrast to Vcan and Postn, Tnc was concentrated on the ventricular side and towards the 
base of wildtype E16.5 semilunar valve cusps (Fig. 3M, O) (Lincoln et al. 2004; Hinton 
et al. 2006). Reduced Tnc expression in Nfatc1Cre;Brg1F/F embryos was especially 
apparent in the left cusps of both aortic and pulmonic valves (Fig. 3N, P), correlating 
with the sites of elevated Postn. Together, the mislocalized ECM indicates a loss of 
patterning of the semilunar valve cusps into distinct base and distal regions in 
Nfatc1Cre;Brg1F/F embryos. Mechanistically, the disrupted ECM pattern could reflect the 
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misexpression of locally restricted ECM or ECM-modifying transcripts and/or altered 
organization of distinct valve interstitial cell populations. 
Figure 3. Altered localization and levels of ECM in Nfatc1Cre;Brg1F/F semilunar valves.  
(A-H) Widefield fluorescence images of anti-Versican (Vcan) antibody stained sections of 
E16.5 wildtype and Nfatc1Cre;Brg1F/F embryos. (I-P) Representative confocal imaged 
cryosections of E16.5 wildtype and Nfatc1Cre;Brg1F/F semilunar valves fluorescently 
immunostained for Periostin (Postn) (I-L) or Tenascin C (Tnc) (M-P) (n=3, paired control and 
Brg1-deficient valves). Pulmonic (PV) or aortic (AoV) valves are shown as indicated. ECM 
proteins are shown in green/gray scale (A-D) or cyan (I-P). Hoechst-stained nuclei are blue. 
White arrowheads mark areas of normal protein expression. Yellow arrowheads show regions 
with broadened (Vcan), broadened/increased (Postn) or decreased (Tnc) levels. Scale bars: 100 
µm. 
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Nfatc1Cre;Brg1F/F semilunar valves have reduced endocardial-derived mesenchyme 
Semilunar valve mesenchyme is derived from endocardial, neural crest, and possibly 
additional lineages that have inconsistently been reported to populate different regions of 
semilunar valve cusps (Jiang et al. 2000; de Lange et al. 2004; Nakamura et al. 2006; Ma 
et al. 2008; Jain et al. 2011; Engleka et al. 2012; Phillips et al. 2013). To explore if the 
aberrant ECM pattern in Nfatc1Cre;Brg1F/F embryos reflected misorganization of distinct 
mesenchymal sub-populations, we fate mapped endocardial cells and their mesenchymal 
derivatives in Nfatc1Cre;Brg1F/F hearts using the Rosa26RmTmG Cre reporter line 
(Muzumdar et al. 2007) while double-staining for Tnc and Postn. In E16.5 wildtype 
embryos, EMT-derived cells were scattered throughout the right and left pulmonic valve 
cusps but were enriched towards the Tnc-rich base of the cusp (Fig. 4A, B). In 
Nfatc1Cre;Brg1F/F embryos, EMT-derived cells were reduced, likely accounting for the 
loss of the Tnc-high field seen in the base of the left semilunar valve cusps (Fig. 4C, D). 
The mitral valves of Nfatc1Cre;Brg1F/F embryos had normal Tnc expression in spite of 
substantial loss of Brg1 protein in mitral valve mesenchyme (Figs. 4E, F and S4C, F). 
Therefore, the decreased Tnc in Nfatc1Cre;Brg1F/F semilunar valve cusps likely reflected 
depleted EMT-derived mesenchyme rather than BAF-dependent control of Tnc 
expression. The high Postn-expressing areas in the pulmonic valve cusps of 
Nfatc1Cre;Brg1F/F embryos were largely populated by non-labeled cells (Fig. 4G-J). 
Therefore, the increased Postn originated from a non-cell-autonomous response to 
endocardial-lineage Brg1 deletion. These results further indicate that, at least for the left 
cusps, specialized EMT-derived mesenchyme produces the concentrated Tnc in the base 
of the semilunar valves. The depletion of these cells upon loss of endocardial-lineage 
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Brg1 accounts for the bulbous valves that lack robust basal cusp regions and therefore fail 
to restrain Postn-expressing cells to the distal cusp. 
 
 
 
 
Figure 4. Disorganized extracellular matrix in endocardial Brg1-deficient semilunar valves 
reflects an altered organization of distinct mesenchymal lineages. 
Immunofluorescence images of E16.5 control (Nfatc1Cre;Brg1F/+;R26RmTmG) or endocardial 
Brg1-deficient (Nfatc1Cre;Brg1F/F;R26RmTmG) embryo sections simultaneously stained for GFP 
to monitor Nfatc1Cre-lineage cells and either Tenascin C (Tnc) (A-F) or Periostin (Postn) (G-J). 
Pulmonic valves (A-D, G-J) and mitral valves (E-F) are shown.  All panels are confocal images 
except (E-F), which are widefield images. Overlay images show Tnc or Postn in red, GFP 
indicating Nfatc1Cre-lineage cells in green, and Hoechst-stained nuclei in blue. Magnified 
regions are outlined in dashed boxes. White arrowheads denote normal ECM localization and 
yellow arrowheads represent either deficient (Tnc) or ectopic (Postn) ECM protein. Scale bars: 
100 µm. 
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We quantitatively assessed the depletion of EMT-derived semilunar valve mesenchyme 
upon endocardial Brg1 deletion by scoring the fraction of GFP-labeled pulmonic valve 
mesenchymal cells in Nfatc1Cre;Brg1F/F;Rosa26RmTmG embryos (Fig. 5A, B).  At E16.5, 
there was a significant decrease in the number of Nfatc1Cre-derived mesenchymal cells in 
both left and right pulmonic cusps (Fig. 5E, F, J). In contrast, the mitral valve retained its 
full complement of EMT-derived cells  (Fig. 5G, H). At E14.5, when the semilunar valve 
defects first became evident, a similar decrease in the number of EMT-derived cells was 
observed in the left cusp of Nfatc1Cre;Brg1F/F pulmonic valves (mean 33.3%; P < 0.04) 
(Fig. 5C, D, I). A comparable trend of reduced EMT-derived cells likewise was seen in 
the right cusp.  Given Nfatc1Cre;Brg1F/F SLVs were of normal volume and cell number, 
the change in the ratio of mesenchyme of different origins suggested non-EMT derived 
mesenchyme expanded to replace the scarce EMT-derived population.   
 
 
Figure 5 (next page). A depleted pool of EMT-derived mesenchyme in endocardial Brg1-
deficient semilunar valves is replaced by increased proliferation of other mesenchymal 
lineage(s).  
(A-H) Sections of Nfatc1Cre;Brg1F/+;R26RmTmG and Nfatc1Cre;Brg1F/F;R26RmTmG embryos 
(pulmonic valve except mitral valve in (G, H); genotype and age as indicated) immunostained for 
GFP (Nfatc1Cre-lineage derived cells, green) and nuclei (Hoechst-stained, purple). Arrowheads 
indicate EMT-derived mesenchymal cells at the pulmonic valve cusp base near the cushion-
myocardium boundary. (I, J) Quantification of the relative contribution of Nfatc1Cre-lineage 
pulmonic valve mesenchyme in control (Brg1F/+) and endocardial Brg1-deficient embryos 
(Brg1F/F) at E14.5 (I) and E16.5 (J). Left (L-PV) and right (R-PV) cusps are scored separately. 
The percentile fraction of Nfatc1Cre-lineage mesenchyme for each embryo is normalized to the 
mean of corresponding littermate wildtype samples. The mean absolute percentage of labeled and 
unlabeled cells is shown within individual bars of the chart (n=5). (K-L) E14.5 wildtype 
(Nfatc1Cre;Brg1F/+;R26RmTmG) (K) and Nfatc1Cre;Brg1F/F;R26RmTmG (L) pulmonic valve sections 
stained with GFP (Nfatc1Cre-lineage, green), EdU-incorporating proliferating cells (red), and 
Hoechst (nuclei, blue). White arrows denote EdU+, non-Nfatc1Cre-lineage mesenchymal cells.  
(M) Quantitation of the proliferation rate of Nfatc1Cre- and other-lineage pulmonic valve 
mesenchyme in E14.5 control and Nfatc1Cre;Brg1F/F embryos. The mean absolute fraction of 
EdU-incorporated cells for each condition is shown. For all graphs, error bars show one standard 
deviation of the mean. Asterisks indicate a significant difference (P < 0.05, two-tailed Student’s t-
tests). NS: not significant; GFP+: Nfatc1Cre-lineage labeled mesenchyme; Non-LL: non-Nfatc1Cre-
lineage labeled mesenchyme. Scale bars: 100 µm. 
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EMT-derived cells of Nfatc1Cre;Brg1F/F SLVs could be reduced due to a change in their 
net growth rate and/or deficient EMT when the cells were first generated. To distinguish 
between these possibilities, we examined proliferation rates by EdU incorporation in 
EMT-lineage traced wildtype and Nfatc1Cre;Brg1F/F embryos. Residual EMT-derived 
mesenchyme and endocardial cells proliferated normally (Fig. 5K-M). In contrast, we 
observed a nearly two-fold increase in EdU-incorporated non-Nfatc1Cre-lineage-labeled 
mesenchymal cells (Fig. 5M). Therefore, this specialized cushion mesenchyme, likely of 
NCC and dOFT cushion origins, proliferated to compensate for the deficient EMT-
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derived pool. Therefore, Brg1 is not inherently required in cushion mesenchyme for cell 
growth or survival and origins of the semilunar valve defects in Nfatc1Cre;Brg1F/F 
embryos likely rest earlier in outflow tract development when EMT-derived cells are 
generated. 
 
Semilunar valve defects originate from deficient pOFT EMT 
To determine if outflow tract EMT was disrupted in Nfatc1Cre;Brg1F/F embryos, we 
examined cushion development at E10.5, less than 24 hours after EMT onset. The pOFT, 
but not the NCC-populated dOFT cushions of Nfatc1Cre;Brg1F/F embryos contained 
approximately half the normal number of mesenchymal cells (p < 0.022) (Fig. 6A, B, E). 
As expected, the AVC cushions were normal (Fig. 6C-E). We used the Rosa26RmTmG 
reporter line to confirm the deficient pOFT mesenchyme in E10.5 Nfatc1Cre;Brg1F/F 
embryos represented a loss of EMT-derived cells (Fig. 6F-G). A reduced pOFT with 
fewer lineage-traced EMT-derived cells persisted at E11.5 in endocardial Brg1-deficient 
embryos (Fig. 6H-K).  We further explored a potential primary pOFT EMT defect in 
Nfatc1Cre;Brg1F/F embryos using collagen gel explant assays (Runyan and Markwald 
1983) and a Nfatc1Cre-driven lineage tracing approach to brightly labeled EMT-derived 
cell nuclei with GFP. E10.0 Nfatc1Cre;Brg1F/F;Rosa26RrtTA;TRE:H2B-GFP OFT cushion 
explants produced significantly fewer GFP+ mesenchymal cells (p < 1.0E-4) (Fig. 6L-N). 
These results confirmed that endocardial deletion of Brg1 driven by Nfatc1Cre produced a 
modest EMT defect in the pOFT but not AVC cushions. 
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We questioned whether the isolated pOFT EMT defect in Nfatc1Cre;Brg1F/F embryos 
represented a specific BAF complex role in pOFT endocardium, or if the induction of Cre 
activity in the Nfatc1Cre line was too late to remove Brg1 in AVC endocardial cells prior 
to EMT.  Supporting this latter possibility, EMT occurs earlier in the AVC than pOFT 
(Camenisch et al. 2002).  Further, Nfatc1Cre;Brg1F/F embryos did not exhibit a widespread 
loss of endocardial Brg1 protein until E10.5 (Fig. S8, Fig. S9). To achieve an earlier 
deletion, we used Tie2:Cre with the floxed Brg1 alleles to remove endocardial Brg1 by 
E9.5 (Stankunas et al. 2008). E9.75 Tie2:Cre;Brg1F/F embryos displayed a near complete 
absence of EMT in both the pOFT and AVC cushions (Fig. 6O-R). Therefore, 
endocardial BAF complex-mediated chromatin remodeling is required for both AVC and  
 
Figure 6 (next page). Reduced EMT-derived semilunar valve mesenchyme in 
Nfatc1Cre;Brg1F/F embryos originates from deficient pOFT EMT, a process that generally 
requires Brg1 function. 
(A-D) H&E stained sagittal sections of E10.5 wildtype and Nfatc1Cre;Brg1F/F embryos. The 
proximal (pOFT) and distal (dOFT) outflow tract (A, B) and atrioventricular canal (AVC) 
cushions (C, D) are shown. Arrowheads indicate pOFT mesenchyme. (E) Scoring of 
mesenchymal cells populating the pOFT or AVC cushions in E10.5 wildtype and 
Nfatc1Cre;Brg1F/F embryos. Each point shows one embryo and all values are normalized to the 
mean of littermate wildtype samples. Asterisk denotes a significant difference (two-tailed 
Student’s t-tests). (F-G, J-K) Widefield fluorescence images of OFT regions from transverse 
sectioned E10.5 (F, G) or sagittal sectioned E11.5 (J, K) embryos. Tissue is immunostained 
for GFP (for Nfatc1Cre-lineage tracing, green) and Nfatc1 (endocardium, red). Nuclei are 
stained with Hoechst (blue). Control (Nfatc1Cre;Brg1F/+;R26RmTmG; F, J) and 
Nfatc1Cre;Brg1F/F;R26RmTmG (G, K) embryos are shown. (H, I) H&E stained sagittal sections of 
E11.5 wildtype and Nfatc1Cre;Brg1F/F embryos. Arrowheads indicate pOFT mesenchyme. (L, 
M) Brightfield and fluorescence overlaid images of collagen gel OFT explants from E10.0 
control and Nfatc1Cre;Brg1F/F embryos (24 hours post-dissection). All embryos additionally 
carry R26RrtTA and TRE:H2B-GFP transgenes and explants are treated with doxycycline to 
induce H2B-GFP expression (to label Nfatc1Cre-lineage mesenchymal cells, green). White 
arrowheads denote EMT-derived (GFP+) mesenchymal cells. Brg1 is required for all cushion 
EMT. H&E stained sections showing AVC (O, P) and pOFT (Q, R) cushions of wildtype and 
Tie2:Cre;Brg1F/F E9.75 littermate embryos. Arrowheads denote either the presence or a 
depleted/absent pool of endocardial-derived cushion mesenchymal cells. Arrows in (Q, R) 
show neural crest-origin mesenchyme within the dOFT cushions. Scale bars: 100 µm. 	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pOFT EMT. The serendipitous timing of Brg1 deletion at the onset of EMT accounts for 
the unique and partial pOFT EMT deficiency seen in Nfatc1Cre;Brg1F/F embryos. 
 
To assess potential ongoing endocardial roles for Brg1, we used an additional Cre line, 
Nfatc1enh:Cre, to delete floxed Brg1 in cushion endocardial cells that undergo minimal 
or no EMT (Wu et al. 2011). Lineage tracing experiments using Rosa26RmTmG confirmed 
that Nfatc1enh:Cre was active only in cushion endocardial cells and not valve 
mesenchyme at E14.5 (Fig. S10A-D). Nfatc1enh:Cre;Brg1F/F embryos exhibited no 
change in semilunar valve morphology at E14.5 or E16.5 (Fig. S10E-L).  The absence of 
major post-EMT roles for Brg1 in either endocardium or cushion mesenchyme suggests 
that pOFT EMT is the disrupted process that “triggers” semilunar valve defects in 
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Nfatc1Cre;Brg1F/F embryos. The ultimate manifestation of disorganized ECM and poorly 
patterned valves thus represents a progression towards a disease-like state, driven by 
imperfect compensation by non-EMT derived and functionally distinct mesenchymal 
cells. 
 
Transcriptional profiling of Brg1-deficient cardiac cushions reveals novel regulators 
We sought to characterize misexpressed transcripts in Nfatc1Cre;Brg1F/F embryos that 
could characterize and/or promote the progression of their EMT-deficient SLVs into a 
diseased state. None amongst a select group of semilunar valve disease-associated 
transcripts were misexpressed by quantitative qRT-PCR at E14.5 (Fig. S11). Therefore, 
we used RNA-Seq to identify differences between the E14.5 SLV transcriptomes of 
wildtype and Nfatc1Cre;Brg1F/F embryos. We identified 43 differentially expressed genes 
(DEGs) (22 increased, 21 decreased; Table S1) and selected seven for further study (see 
Supplemental Materials). We used quantitative RT-PCR on additional sets of dissected 
tissue to confirm both up-regulated (Nptx1, Clec7a and Cthrc1) and down-regulated 
(Col23a1, Enpp2, Irf6 and Smoc1) genes were significantly misexpressed at E14.5. At 
E16.5, Clec7a, Cthrc1, and Nptx1 remained upregulated, suggesting they define a 
progressively worsening disease-like state (Fig. 7B-C). Conversely, Col23a1, Enpp2 and 
Smoc1 transcripts were no longer decreased at E16.5, indicating these genes were 
transiently misexpressed in endocardial-Brg1 deficient embryos at the onset of overt 
semilunar valve defects. 
 
	   31 
To characterize the cell type-specific expression of these potential regulators of SLV 
development and disease, we performed in situ hybridizations on E14.5 wildtype and 
Nfatc1Cre;Brg1F/F embryos. Nptx1, a member of the neuronal pentraxin family (Omeis et 
al. 1996; Boles et al. 2014) was expressed in the most distal endocardial cells of the 
pulmonic valve and had notbly higher levels in endocardial Brg1 mutants (Fig. 7D-E). 
However, no change in Nptx1 expression was observed in the mitral valve, suggesting 
that Nptx1 is an OFT endocardial-specific transcript (Fig. S12A-D). In contrast, the 
collagen triple helix repeat containing 1, Cthrc1 (Pyagay et al. 2005), protein was found 
only in mesenchymal cells at the very base of the cusps where cushion-derived tissue met 
adjacent myocardium. As expected, cushion mesenchyme Cthrc1 levels were higher in 
Nfatc1Cre;Brg1F/F embryos (Fig. 7F-G). Further, Cthrc1 was increased in aortic valve 
mesenchyme and became ectopically expressed in both valve and ventricular 
endocardium (Fig. S12E-J). Enpp2, a secreted phospholipase required for 
lysophosphatidic acid production (Tokumura et al. 2002; Umezu-Goto et al. 2002), and 
Irf6, an interferon-responsive factor (Kondo et al. 2002), were both specifically expressed 
in endocardial cells on the arterial side of wildtype pulmonic valves. Enpp2 and Irf6 were 
largely absent in the endocardium from Nfatc1Cre;Brg1F/F semilunar valves (Fig. 7H-K, 
Fig. S12K, M, O, R). In contrast, pulmonic arterial endothelial expression of Irf6 was 
unchanged (Fig. S12Q, T). Given their misexpression in endocardial and/or EMT-derived 
cells, these four DEGs could represent directly repressed (Nptx1, Cthrc1) or activated 
(Enpp2, Irf6) targets of BAF complex chromatin remodeling. Further studies are merited 
to test their potential roles in valve development and disease and/or broader utility as 
markers of SLV disease progression.  
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Figure 7. RNA-seq identifies novel semilunar valve expressed transcripts misexpressed 
in endocardial lineage Brg1-deficient valves. 
(A) Select differentially expressed genes (DEGs) identified from an RNA-seq analysis 
comparing two paired samples of wildtype and Nfatc1Cre;Brg1F/F dissected E14.5 heart valve 
tissue. 26 DEGs (green-upregulated; red-downregulated) are listed with fold change and false 
discovery rate (FDR). Transcripts of particular interest are highlighted. (B, C) Quantitative 
RT-PCR expression studies of the highlighted DEGs in (A) E14.5 (B) and E16.5 (C) valves. 
Bar heights represent the log-base-2 fold change in gene expression (linear mean fold change 
value indicated below bars) between Nfatc1Cre;Brg1F/F and wildtype tissue. Error bars 
represent one standard deviation with the additional error bars centered along the x-axis 
showing the variation between wildtype samples. Double asterisks indicate a significant 
difference including a Bonferroni correction (one-tailed Student’s t-test, n=7, P < 0.007); 
single asterisk indicates a P < 0.05. (D-K) RNA in situ hybridizations for indicated transcripts 
on pulmonic valve sections of E13.5 wildtype or littermate Nfatc1Cre;Brg1F/F embryos. 
Arrowheads highlight areas of highest transcript expression. Scale bar: 100 µm. 
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DISCUSSION 
Endocardial Brg1 deletion establishes a model of semilunar valve disease with 
origins in deficient EMT 
We describe a new mouse model of semilunar valve disease caused by deletion of Brg1 
in the endocardial lineage. Nfatc1Cre;Brg1F/F mice develop thickened, blunted, and 
occasionally fused valve cusps that become myxomatous in surviving adults. We map the 
origins of these phenotypes to disrupted pOFT EMT, one of the earliest steps in valve 
development. OFT mesenchyme of other origins, likely cardiac neural crest, compensates 
for the deficient EMT-derived cells by relatively increased proliferation but is 
incompetent to fully generate the complex 3-dimensionally patterned interstitium of a 
tricuspid semilunar valve. As such, the cellular and extracellular changes that 
characterize the abnormal semilunar valves represent secondary responses to a disrupted 
system, rather than reflecting later developmental or physiologic roles of Brg1. 
 
Chromatin remodeling contributes to endocardial cushion EMT 
Early deletion of floxed Brg1 in all endocardial cells using the Tie2:Cre driver disrupted 
EMT in both the AVC and pOFT cushions. These results establish chromatin remodeling 
as a component of the transcriptional networks that promote EMT. Endocardial Brg1 
deletion does not have a significant effect on endocardial cell death or proliferation 
(Stankunas et al. 2008), suggesting that cushion endocardial BAF complexes have a 
relatively specific transcriptional role in EMT. A simple explanation is that the BAF 
complex has a common chromatin remodeling role in all EMT processes, whether in the 
endocardial cushions or other developmental/disease situations. Consistent with this 
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possibility, the Baf60c subunit of the BAF complex is required for EMT in cancer cell 
lines (Jordan et al. 2013) and Brg1 interacts with the Zeb1 transcription factor to promote 
a terminal step in the mesenchymal transition of MCF7 cells (Sánchez-Tilló et al. 2010). 
Alternatively, effectors of upstream EMT-inducing signaling pathways, such as TGF-beta 
or Notch signaling, may recruit BAF complex activity to induce EMT. In support of these 
possibilities, both the Smad2/3 effectors of TGF-beta signaling and activated Notch1, 
each of which has been implicated in both AVC and pOFT EMT, cooperate with the BAF 
complex and/or induce chromatin remodeling in other circumstances (Takeuchi et al. 
2007; Xi et al. 2008). 
 
The semilunar valve interstitium is organized into regions enriched with 
mesenchyme of different origins  
Multiple lineage tracing studies suggest a complex patterning of multi-origin 
mesenchymal populations within semilunar valves (Jiang et al. 2000; de Lange et al. 
2004; Nakamura et al. 2006; Jain et al. 2011; Phillips et al. 2013). Our simultaneous 
study of the localization of valve ECM components with Nfatc1-based lineage tracing 
indicates that the patterned ECM composition of semilunar valves is conferred by the 
regulated organization of mesenchymal cells with differential competency to produce 
ECM proteins. For example, EMT-derived cells likely produce the Tnc-enriched base of 
the left semilunar valve cusps that is depleted in Nfatc1Cre;Brg1F/F embryos. As a 
corollary, the increased Postn seen in Nfatc1Cre;Brg1F/F embryos could reflect an 
expanded non-EMT origin (likely neural crest-derived) mesenchyme that continues to 
fulfill its normal role of secreting Postn. This general concept of semilunar valve 
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patterning provides a framework to understand when and how valve regulators function 
and comprehend how various mechanisms can generate valve defects. 
 
Interpreting mouse models of semilunar valve disease 
A number of other mouse models exhibit either bicuspid aortic valve and/or semilunar 
valve disease-like phenotypes. When bicuspid, the aortic valves of Nfatc1Cre;Brg1F/F 
embryos display either a RCC-NCC or, more frequently, what in humans is the rarest 
LCC-NCC subtype (Fernandes et al. 2004; Fernández et al. 2009; Kang et al. 2013). 
Grewal et al. proposed that the “type I” subtype showing fusions between RCC-LCC 
cusps is caused by a deficiency of NCCs (Jain et al. 2011; Phillips et al. 2013; Grewal et 
al. 2014).  In contrast, “type II” fusions (RCC-NCC) are suggested to be of second heart 
field (SHF) origin, which could encompass pOFT EMT defects given the outflow tract’s 
SHF origins. Consistent with this idea, the Nos3-deficient mouse model of BAV develops 
RCC-NCC fusions and may, like the Brg1-deficient model, originate from defective 
EMT (Fernández et al. 2009). Whether a RCC-NCC or LCC-NCC fusion occurs could 
reflect the severity of the EMT disruption, reflected by the variable Brg1 deletion in 
Nfatc1Cre;Brg1F/F embryos.  
 
Could other mouse models of thickened and disorganized semilunar valves also have 
origins in pOFT EMT defects? Supporting this hypothesis, several other models disrupt 
known or potential EMT regulators, including the TGF-b effector Smad2 (combined with 
Adamts5), TGF-b family receptors (Alk2), Gata-family transcription factors (Gata5), 
Notch signaling, and BMP signaling (BMP4) (Camenisch et al. 2002; Timmerman et al. 
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2004; Ma et al. 2005; Wang et al. 2005; McCulley et al. 2008; Laforest and Nemer 2011; 
Moskowitz et al. 2011; Thomas et al. 2012; Bosse et al. 2013; Dupuis et al. 2013). 
Testing this idea would require directly examining these mice for pOFT EMT defects as 
well as monitoring their valves for a deficient Tnc-expressing base region, as observed in 
the endocardial Brg1-deficient model. Another set of models, for instance Cxcr7KO, 
EgfrKO;Ptpnll+/- and Hb-egfKO have clear hyperplastic semilunar valve cusps (Chen et al. 
2000; Jackson et al. 2003; Yu et al. 2011), which we did not observe in Nfatc1Cre;Brg1F/F 
embryos by EdU incorporation and cusp volume measurements. We postulate that this 
manifestation of a semilunar valve defect likely originates in misregulated proliferative 
signals rather than deficient EMT. However, our combined EdU incorporation and 
lineage tracing of Nfatc1Cre;Brg1F/F valves does show how a subset population of 
semilunar valve mesenchyme can have an increased proliferative rate even while overall 
mesenchyme proliferation is unchanged.  In endocardial Brg1-deficient mice, this effect 
is non-autonomous, with non-EMT derived mesenchyme increasing their relative rate of 
proliferation to compensate for the deficient EMT-derived cells. This observation also 
supports the idea that different valve mesenchymal populations communicate to modulate 
each other’s growth and organization (Jain et al. 2011; Wu et al. 2011). By extension, 
neural crest (or other origin) mesenchyme could also be genetically perturbed in 
semilunar valve disease, as indicated by Rho kinase and Pax3 deficient models (Jain et al. 
2011; Phillips et al. 2013). 
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RNA-Seq of the endocardial Brg1-deficient valves uncovers potential novel 
regulators of semilunar valve development and disease 
Our transcriptomics study of E14.5 Nfatc1Cre;Brg1F/F valve regions identified a number 
of such potential novel regulators of valve development and/or disease biomarkers. For 
example, we found misexpressed negative regulators of both BMP signaling (Smoc1, 
(Thomas et al. 2009) and TGF-beta signaling (Mirlet7a-1, (Colas et al. 2012), two 
pathways that can be aberrantly active in mesenchyme of developmentally abnormal 
valves (Conway et al. 2011). Our subsequent RNA ISH analysis revealed that several of 
the misexpressed genes had highly specific and unique expression patterns, showing the 
high degree of cellular specialization within semilunar valves. For example, Nptx1 was 
expressed only in distal tip endocardium of both semilunar valves. Similarly, Enpp2, and 
Irf6 also are normally expressed in subsets of endocardial cells. In contrast, Cthrc1 
transcripts were restricted to mesenchyme at the base of the semilunar valve. Given their 
altered expression in endocardial or possible EMT-derived cells (Cthrc1) of 
Nfatc1Cre;Brg1F/F valves, each of these genes may be a direct target of BAF complex 
activation or repression. Indeed, Brg1 binds near the 5’ end of both Irf6 and Nptx1 genes 
by ChIP-Seq studies of E11.5 hearts (Li et al. 2013). 
 
Endocardial Brg1-deficient model of semilunar valve disease distinguishes between 
the origins and progression of semilunar valve disease 
Our interpretation of the valve defects in Nfatc1Cre;Brg1F/F embryos provides an 
explanation for how semilunar valve disease, including thickened and fused cusps, could 
commonly originate in a sensitive EMT process of early valvulogenesis. Disease 
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progression then represents the “best effort” of robust developmental networks to 
produce and maintain a functional valve. As such, a genetic understanding of inherited 
semilunar valve disease may frequently reflect EMT mechanisms, while efforts to 
therapeutically attenuate disease progression may merit focusing on manipulating 
compensating cell lineages and/or their ECM products. For the former goal, mutations in 
BAF component genes themselves are unlikely to be causes of aortic valve disease given 
the pleiotropic roles of BAF complex driven chromatin remodeling. However, interacting 
transcription factors and target genes of BAF-direct chromatin regulation during EMT 
would represent attractive candidate disease genes. For the latter goal, our RNA-Seq 
analysis of progressively worsening valves in endocardial Brg1-deficient mice has 
identified new candidate regulators with highly specific expression patterns that may 
characterize or even drive progression of an anatomically abnormal valve into a disease 
state. 
 
BRIDGE TO CHAPTER III 
My work in Chapter II demonstrates that the BAF complex is required for patterning of 
the semilunar valves. I show that Nfatc1Cre-expressing EMT-derived cells are essential 
for regulating other mesenchymal populations during OFT valve maturation and ECM 
organization. Loss of Brg1 in the endocardium results in deficient number of endocardial-
derived mesenchymal cells during cushion formation. In Chapter III, I will describe the 
mechanism of Brg1-dependent EMT in endocardial cells.  
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CHAPTER III 
 
BRG1 IS REQUIRED FOR TERMINAL STEPS OF ENDOCARDIAL-TO-
MESENCHYMAL TRANSFORMATION 
 
Brynn N. Akerberg, Vidusha Devasthali, Kryn Stankunas. In preparation. Copyright 2015. 
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INTRODUCTION 
Cardiac valve development is a complex, multistep process that gives rise to two distinct 
sets of heart valves in mammals. These intricate structures govern blood flow within the 
heart, as well as to other regions of the body. The semilunar valves (aortic and pulmonic) 
are morphologically distinct than that of the atrioventricular-derived valves (mitral and 
tricuspid). Differences in formation and functions of these valves are attributed to 
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dissimilarities of mesenchyme origin and formation of these specific structures is 
precisely regulated during development. 
 
Valvulogenesis first requires the formation of primitive endocardial cushions, which 
subsequently undergo a morphogenesis process to remodel the cushions into intricate 
valve structures. The formation of endocardial cushions is driven by an endothelial-to-
mesenchymal transformation (EMT) of specialized endocardial cells surrounding 
‘swellings’ of cardiac jelly (proteoglycan-rich) regions beginning at embryonic day 9.5 
(E9.5) (Eisenberg and Markwald 1995). The atrioventricular canal (AVC) cushion is 
entirely populated by endocardial-derived mesenchymal cells (Person et al. 2005). 
Conversely, the outflow tract (OFT) cardiac cushion is populated with similarly 
transforming endocardial cells in its proximal cushions (pOFT) and migratory cardiac 
neural crest-derived mesenchymal cells within the distal cushions (dOFT). Additional 
studies suggest a possible third mesenchymal origin by drawing attention to the 
conflicting data presented by a number of different lineage labeling experiments (Kirby et 
al. 1983; Jiang et al. 2000; Jain et al. 2011; Engleka et al. 2012).  
 
The cellular signals that direct and reinforce EMT during endocardial cushion formation 
have been studied extensively. Particularly, activated Notch and Tgfβ signaling effectors 
in the endocardium are essential for induction of EMT in the AVC cushion (Ramsdell 
and Markwald 1997; Camenisch et al. 2002; Timmerman et al. 2004; Chang et al. 2011). 
Additionally, myocardial Bmp2 is required to initiate and restrict endocardial cushion 
formation through activation of Tbx2 (Yamada et al. 2000; Ma et al. 2005). The 
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transcriptional regulation of how these signaling pathways cooperate to promote 
endocardial cushion formation have been studied considerably, but an understanding of 
chromatin structure and regulation during this process remains to be investigated.  
 
Gene activation or repression can, in part, be facilitated by chromatin state and chromatin 
remodeling proteins that promote nucleosome repositioning or replacement (Tolstorukov 
et al. 2013). An important chromatin remodeling complex, Brg1-associated factor (BAF) 
complex is required for early embryonic development, such that null alleles for the core 
ATPase subunit, Brg1, are peri-implantation lethal (Bultman et al. 2000).  
 
Brg1 is required in the endocardium for both AVC and pOFT cardiac cushion formation. 
Tie2:Cre;Brg1F/F embryos exhibit impaired endothelial-to-mesenchymal transformation 
in both the atrioventricular canal (AVC) and the proximal-outflow tract (pOFT) 
endocardial cushions (Akerberg et al. 2015b). However, the mechanism is unknown. 
Here, we show that loss of Brg1 in endocardial cells results in a failure to complete 
mesenchymal transformation. Brg1-deficient transforming endocardial cells activate early 
mesenchymal transcription factors, such as Twist1, but unsuccessfully upregulate Sox9 
and fail to downregulate endocardial genes. The intermediate mesenchymal cells remain 
associated with the endocardium and the result is a ‘stacking’ phenotype of the 
accumulating Brg1-deficient cells. We propose that Brg1 is required for a terminal 
process of EMT in transforming endocardial cells.  
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MATERIAL AND METHODS 
Mice 
Brg1-floxed mice were generated from Dr. Pierre Chambon’s laboratory and Tie2:Cre 
mice were obtained from Jackson Laboratory (Sumi-Ichinose et al. 1997; Kisanuki et al. 
2001). Mouse husbandry and procedures were permitted and monitored by the University 
of Oregon’s Institutional Animal Care and Use Committee. 
 
Tissue processing and sectioning 
Mouse embryos were fixed overnight in 4% PFA/PBS at 4°C. Fixed tissue was washed 3-
5X with PBS and then equilibrated overnight with PBS at 4°C. Embryos were dehydrated 
with a stepwise ethanol series the following day to 100% ethanol and left overnight at 
4°C.  Tissue was cleared with xylenes the next day, prior to paraffin embedding. 7 µm 
paraffin sections were used for histological or immunofluorescent staining. 
 
Histology 
Paraffin tissue sections were used for hematoxylin and eosin (H&E) staining with 
standard regents and procedure (Ricca Chemical Company; Sigma-aldrich). Slides were 
mounted with glass coverslips and permount mounting media after stain (Electron 
Microscopy Sciences). 
  
Immunostaining 
Paraffin tissue sections were de-paraffinized with xylenes and gradually rehydrated with 
an ethanol series to distilled water. Pressure cooker-based (10’ incubation) antigen 
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retrieval methods were performed for all immunofluorescent stains in either a citrate-
based 1X DAKO (Dako) or 1mM EDTA, 0.1% Tween-20 solutions and slowly brought 
to room temperature. Tissue was blocked with 10% normal goat serum (NGS) in PBS for 
at least 1 h at room temperature and incubated with primary antibodies overnight at 4°C 
(anti-Beta-catenin [1:250], CST; anti-Brg1 [1:500], SCBT; anti-Cleaved caspase 3 
[1:250], CST; anti-cTnT [1:250], DSHB; anti-Lef1 [1:250], CST; anti-Nfatc1 [1:250], 
Abcam; anti-PCNA [1:500], Sigma-aldrich; anti-Twist1 [1:100], SCBT; anti-Sox9 
[1:250], SCBT; anti-Vimentin [1:250], GeneTex. Fluorescent Alexa-conjugated 
antibodies were used at 1:500 (Life Technologies). All antibodies were diluted in PBS 
and 5% NGS during incubation with slides. 
 
RESULTS 
As previously described, Tie2:Cre;Brg1F/F embryos exhibit extreme cardiovascular and 
hematopoietic defects (Griffin et al. 2008; Stankunas et al. 2008). These studies showed 
that endothelial Brg1-deficient embryos exhibit severe vascular defects and fail to 
properly form ventricular trabeculae. Our recently published data suggests that 
Tie2:Cre;Brg1F/F embryos exhibit an endocardial cushion EMT defect (Akerberg et al. 
2015b). We sought to characterize this defective step in valvulogenesis more rigorously. 
Loss of Brg1 protein in all endothelial and hematopoietic cells can cause early embryonic 
lethality by E10.5. Tie2:Cre;Brg1F/F embryos appeared smaller and less vascularized 
than wildtype littermates at E10.25 (Fig. 1A, F). By E9.75, we observed that nearly all 
endocardial cells and EMT-derived cells in the developing heart were void of Brg1 
protein (Fig. 1B, C, E, F). Hematoxylin and eosin (H&E) histology staining revealed that 
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Tie2:Cre;Brg1F/F displayed severe endothelial-to-mesenchymal transformation (EMT) 
defects in the atrioventricular canal (AVC) and proximal-outflow tract (pOFT) cardiac 
cushions compared to wildtype littermates (Fig. 1G, H, J, K). We quantified the EMT 
defect in Brg1-deficient AVC cushions compared to normal wildtype littermates and 
found that Tie2:Cre;Brg1F/F embryos exhibited a significant defect in EMT at E9.75 with 
nearly 52% decrease in the number of migrating mesenchymal cells (Fig. 1I). This data 
reinforces that Brg1 is required in the endocardium during EMT in both developing 
cardiac cushions. 
 
To determine whether the diminished mesenchyme in the AVC of Tie2:Cre;Brg1F/F 
embryos was a result of transformed cells failing to proliferate, we tested for changes in 
rates of proliferation. We were interested in whether there was a mesenchymal role for 
Brg1 to promote proliferation of the AVC mesenchymal population at E9.75. We 
performed fluorescent immunostaining for proliferating cell nuclear antigen (PCNA) and 
an endocardial marker (Nfatc1). Tie2:Cre;Brg1F/F AVC cushions displayed normal 
wildtype levels of PCNA in both the endocardium and transforming mesenchymal cells at 
E9.75 (Fig. 2A-D). This data further supports our previous findings that Brg1-deficient 
mesenchymal cells (Nfatc1Cre;Brg1F/F embryos) within the developing pulmonic valve 
exhibit no significant difference in the rate of proliferation by EdU incorporation 
(Akerberg et al. 2015a). Taken together, our data shows that Brg1 is dispensable for 
proliferation of mesenchymal cells in the developing AVC.  
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Figure 1. Brg1 is required in endocardial cells for atrioventricular canal and outflow-
tract cushion endocardial-mesenchymal transformation. 
(A, D) Darkfield wholemount images of Tie2:Cre;Brg1F/F and wildtype embryos at E10.25. 
Arrowheads point to developing heart. (B, C, E, F) Embryos were antibody stained for Brg1 
(magenta) protein and Vimentin (green) in Brg1- and wildtype at E9.75. Zoom in panels (C, 
H) depict matched atrioventricular canal (AVC) cushions. White arrowheads indicate Brg1 
expression in (C) wildtype AVC and loss of protein in (H) Tie2:Cre;Brg1F/F AVC. (G, H, J, 
K) Matching H&E stained paraffin sections of wildtype and Brg1- sagittal cardiac cushions 
at E9.75. Wildtype (D) AVC and (E) pOFT cushions compared to Tie2:Cre;Brg1F/F (I) AVC 
and (J) pOFT cushions. Black arrowheads indicate presence or depletion of population 
mesenchyme. (I) Quantification of the EMT defect observed in the AVC of Tie2:Cre;Brg1F/F 
embryos compared to wildtype littermates at E9.75. Data was normalized to wildtype 
mesenchymal cell number within each litter and statistical significance was analyzed using 
student’s t-test, p < 0.05. AVC, atrioventricular canal cushion; pOFT, proximal-outflow tract 
cushion. 
 
	   46 
We hypothesized that an additional reason for decreased mesenchymal cells in in 
Tie2:Cre;Brg1F/F AVC endocardial cushions was due to an increase in programmed 
apoptosis. Analysis of programmed cell death marker, cleaved caspase 3, in 
Tie2:Cre;Brg1F/F cardiac AVC cushions revealed an increased fluorescent signal within 
the partially transformed mesenchymal populations (Fig. 2E, F). We speculated that 
Brg1-mutant AVCs have a unique defect in the EMT process, such that initiation of 
endothelial-mesenchymal transformation is not affected but the migration and complete 
differentiation appears to be hindered. We frequently observed a “stacking” phenotype in 
Tie2:Cre;Brg1F/F AVC cushions, which we defined as migrating endocardial-derived 
cells that remain associated with the endocardium (seen in Fig. 1C, H). 
 
This phenotype is different than other EMT deficiencies described by loss of signaling 
molecules and cardiac transcriptions factors, which fail to initiate EMT (Timmerman et al. 
2004; Ma et al. 2005; Niessen et al. 2008). Furthermore, these findings support our 
previous studies that loss of Brg1 in the endocardium is required for the endothelial-to-
mesenchymal transformation process to populate the OFT and AVC cardiac cushions.  
We next investigated if Tie2:Cre;Brg1F/F AVC cushions displayed changes in known 
transcription factors that are required for endothelial-to-mesenchymal transformation. 
Since loss of Brg1 appeared to affect a specific step of EMT, we hypothesized that 
transcription factors involved in initiating the process would not be changed in Brg1-
deficient AVC cushions. We first analyzed any expression changes for the helix-loop-
helix transcription factor, Twist1 and lymphoid enhancer-binding factor 1, Lef1 
transcription factor that has been linked to the high motility group protein-1. 
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Tie2:Cre;Brg1F/F embryos displayed normal levels of Twist1 in the expected regions for 
EMT-induced endocardium in the AVC compared to wildtype AVC (Fig. 3A-D). Lef1 
Figure 2. Brg1 is not required for proliferation of endocardial nor mesenchymal cells in 
Tie2:Cre;Brg1F/F atrioventricular canal cushions 
(A-D) E9.75 paraffin tissue sections of Tie2:Cre;Brg1F/F and wildtype AVC cushions 
immunostained for proliferating cell nuclear antigen (PCNA) and the endocardial marker 
Nfatc1 (green). (A) Wildtype AVC cushion and zoom in (B) on atrial side-endocardium. (C) 
Matched section of Brg1-deficient AVC and similarly magnified (D) regions compared for 
positive PCNA (red, greyscale) staining. (E, F) E9.75 matching paraffin sections of 
Tie2:Cre;Brg1F/F and wildtype littermate AVC antibody stained for cleaved caspase 3 (CC3, 
green) and myocardial marker, cardiac troponin T (cTnT, pink). White arrowhead denotes 
positive CC3 staining in AVC mesenchyme.  
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expression was restricted to transformed mesenchymal cells and adjacent myocardium in 
wildtype AVC cushions. (Fig. 3B). AVC cushions of Tie2:Cre;Brg1F/F embryos 
exhibited no change in Lef1 expression (Fig. 3D). These results further validate our 
hypothesis that transcriptional initiation of EMT is intact in Tie2:Cre;Brg1F/F and does 
not require functional BAF protein complex. 
 
To determine if a late step during EMT was disrupted by loss of Brg1 in the endocardium, 
we tested whether AVC of Tie2:Cre;Brg1F/F embryos exhibited changes in the sex-
Figure 3. Tie2:Cre;Brg1F/F atrioventricular canal cushions express EMT-specific 
transcription factors 
(A-D) E9.75 paraffin tissue sections of Tie2:Cre;Brg1F/F and wildtype AVC immunostained 
for Twist1 (green/grayscale) and Lef1 (red) transcription factor expression. (A, B) Wildtype 
and (C, D) Tie2:Cre;Brg1F/F AVC cushions with Twist1 (green/grayscale) Lef1 (red) protein 
expression in transforming endocardial cells. White dashed lines denote endocardium-
chamber boundaries. White arrowheads indicate Twist1 expressing cells in the endocardium 
and mesenchyme. atr, atrium; vent, ventricle. 
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determining region Y (Sox9) transcription factor (Wright et al. 1993). Targeted deletions 
for Sox9 have shown it’s required for EMT in the AVC through regulating extracellular 
matrix composition and controlling terminal steps of EMT (Akiyama et al. 2004; Lincoln 
et al. 2007). Sox9 is normally present in mature mesenchymal cell and not as widely 
expressed as Twist1, which appeared in the majority of endocardial cells in the AVC. In 
E9.5 Tie2:Cre;Brg1F/F AVC cushions, fewer transforming endocardial cells expressed 
Sox9 protein (Fig. 4A-D). Wildtype transforming endocardial cells displayed high levels 
of Sox9 when fully migratory and coincident with downregulated endocardial gene 
expression (Fig. 4B).  
 
We tested a hypothesis that transforming endocardial cells in Brg1-deficient AVCs 
remained associated with the endocardium due to a failure to downregulate cell 
adhesionproperties. Tie2:Cre;Brg1F/F AVC cushions were immunostned for Twist1 and 
β-catenin, a component of adherens junctions, at E9.75 and showed drastic changes in β-
catenin cellular localization. Brg1-deficient embryos exhibited increased expression of β-
catenin at the cell-cell contact regions of the intermediate transforming endocardial cells, 
compared to wildtype mesenchymal cells that displayed largely nuclear and cytoplasmic 
β-catenin (Fig. 5A-D). These data suggest that Brg1 directly activates Sox9, which would 
promote completion of EMT in the developing AVC. Further, the inability for 
Tie2:Cre;Brg1F/F AVC cushions to repress endocardial-specific genes is likely due to a 
direct role for Sox9 protein, as null alleles for Sox9 show an inability of endocardial cells 
to repress Nfatc1 (Akiyama et al. 2004). 
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Figure 5. Tie2:Cre;Brg1F/F atrioventricular canal cushions retain cell-adhesion properties 
(A-D) E9.75 paraffin tissue sections of Tie2:Cre;Brg1F/F and wildtype AVC immunostained 
for Twist1 (red, grayscale) and β-catenin (green, grayscale). (A, B) Wildtype AVC were 
assayed with (C, D) Tie2:Cre;Brg1F/F mutant AVC for changes in β-catenin, which was used 
to observe cell-adhesion properties. White arrowheads denote Twist1-positive transforming 
mesenchyme with cytoplasmic/nuclear or cell membrane β-catenin expression in wildtype and 
Tie2:Cre;Brg1F/F AVC tissue respectively.  
Figure 4. Brg1-deficient transforming endocardial cells fail to express Sox9 
(A-D) E9.75 wildtype and Tie2:Cre;Brg1F/F atrioventricular canal (AVC) cushions 
immunostained for transcription factor, Sox9 (red, grayscale) and endocardial marker, Nfatc1 
(green, grayscale). Wildtype (A, B) paraffin tissue compared to Tie2:Cre;Brg1F/F (C, D) 
tissue. White arrowheads indicate Sox9-positive, Nfatc1-depleted cells in wildtype panels and 
Nfatc1-positive cells in Brg1-deficient tissue.  
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DISCUSSION 
Our results indicate that endocardial AVC cushions of Tie2:Cre;Brg1F/F  embryos exhibit 
a specific endothelial-to-mesenchymal defect with a failure to complete transformation to 
a mesenchymal state. The result is a ‘stacking’ phenotype where partially transformed 
endocardial cells remain associated with the endocardium. We show that AVC cushions 
of Tie2:Cre;Brg1F/F  embryos express relatively normal levels of EMT-inducing 
transcription factors, such as Lef1 and Twist1. However, transforming cells Brg1-mutant 
endocardial cells fail to downregulate their endocardial gene expression patterns. We 
attribute this to the inability to activate Sox9 in developing endocardial cushions of 
Tie2:Cre;Brg1F/F embryos. 
 
Sox9 loss of function studies have demonstrated that endocardial cells fail to repress 
genes associated with their endocardial cell identity and fully migrate into the cardiac 
jelly (Akiyama et al. 2004). Furthermore, Sox9 is required to promote ECM remodeling 
in certain types of cancer for metastasis and represses genes associated with epidermal 
identity (Larsimont et al. 2015). We hypothesize that the BAF complex is essential for 
EMT in the developing endocardial cushion to activate the Sox9 locus, which in turn is 
required to repress endocardial-specific genes.  
 
In other systems, loss of Brg1 or other BAF complex subunits can lead to an EMT defect. 
For instance, Baf60c is required to promote epithelial-to-mesenchymal transformation 
through induction of the Wnt5a ligand (Jordan et al. 2013). Similarly, Brg1 appears to 
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have an important role in repressing epithelial cadherins during epithelial EMT (Sánchez-
Tilló et al. 2010). 
  
  
	   53 
CHAPTER IV 
 
CONCLUSIONS 
 
Here, I describe two important findings about the requirements of endocardial 
Brg1 in the valve development and disease. By conditionally targeting Brg1 with two 
temporally distinct endocardial-Cre recombinases, we have identified that the BAF 
complex is initially required in the endocardial cushions during endothelial-to-
mesenchymal transformation. Secondly, a depletion of these endocardial-derived 
mesenchymal cells gives rise to progressive mispatterning of the aortic and pulmonic 
valves. The findings in Chapter II suggest that semilunar valve disease, characterized by 
malformed and myxomatous valve tissue, can arise from 1) an initial disruption in 
endocardial cushion formation that 2) can progress to myxomatous and disrupted valve 
cusps. We propose that a number of mouse models, which produce bicuspid aortic valves 
(BAV), might exhibit an early endocardial cushion defect. Identifying whether other 
mouse models display a distinct ‘origin’ of the valve defect may allow us to categorize 
these types of bicuspid valves, which could lead to insights about the initiation of those 
disease models. Furthermore, I describe in Chapter II how a subtle, yet significant, 
endothelial-mesenchymal transformation (EMT) defect in the proximal-outflow tract 
(pOFT) of Nfatc1Cre;Brg1F/F mutant mice ultimately leads to mispatterning of the 
semilunar valve mesenchyme.  
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Nfatc1Cre;Brg1F/F mutant mice display a semilunar valve defect phenotype at 
E16.5 that we observed as significantly less ‘elongated’ valve cusps that showed an 
increase in overall 2-D area and number of mesenchymal cells. We attribute this defect to 
a change in valve morphology, rather than a hyperplastic phenotype, given that 3-D 
reconstruction of embryonic aortic valves showed no significant increase in volume in the 
Nfatc1Cre;Brg1F/F mutants. By using a transgenic Nfatc1enh:Cre transgenic mouse that 
expresses only in the endocardium of the valves, we  further demonstrate that loss of 
Brg1 in only endocardial cells is not sufficient to generate SLV defects. Thus, 
endocardial-derived mesenchymal cells are necessary for proper interstitial organization 
of the valves. Nfatc1Cre;Brg1F/F adult mice provide a mouse model for left-coronary 
cusp/non-coronary cusp (LCC-NCC) fusions of bicuspid aortic valve disease, where 
LCC-NCC BAVD is the most rare cusp fusion for BAV.  
 
My findings in Chapter II depict a cell autonomous role for the BAF complex in 
semilunar valve formation. Loss of Brg1 in the endocardium causes a significant 
deficiency of EMT-derived mesenchyme in the base-regions of the aortic and pulmonic 
valve cusps that are important for proper extracellular matrix patterning and correlates 
with a depletion of Tenascin C (Tnc). Nfatc1Cre;Brg1F/F semilunar valves respond to 
compensate for the lack of Nfatc1-derived mesenchymal cells, but ultimately do not 
generate a functional and properly patterned valve. Whole transcriptome analysis 
identified a number of differentially changed transcripts in E14.5 Brg1-mutant valves that 
provides insights into potential transcripts that may be associated with the progression of 
the semilunar valve defect.  
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The study in Chapter III aims to address how Brg1 regulates endothelial-to-
mesenchymal transformation (EMT). The EMT defect present in the Nfatc1Cre;Brg1F/F 
mice was only present in the pOFT and can be explained by the timing of Nfatc1Cre  at the 
onset of EMT in the outflow tract. In contrast, the EMT process was well underway in the 
AVC at the time cells Nfatc1Cre begun to label cells and excise floxed Brg1 alleles. Thus 
providing an explanation for an unperturbed AVC cushion in Nfatc1Cre;Brg1F/F mice, as 
well as generating a variable EMT defect phenotype. These results, supported by the 
Tie2:Cre;Brg1F/F embryos exhibiting EMT defects in all cardiac cushions, drove us to 
utilize the endothelial-specific Cre-recombinase (Tie2:Cre) for our studies to determine 
how Brg1 integrates into EMT mechanisms. In Chapter III, we demonstrate that Brg1 is 
essential for a terminal step during EMT in atrioventricular and proximal-outflow tract 
cushions. Specifically, Tie2:Cre;Brg1F/F mutants exhibit an EMT phenotype that results 
in the ‘stacking up’ of transforming endocardial cells near the endocardium. We propose 
that Brg1 is required for a terminal step of EMT and that the initiation of EMT does not 
require a functional BAF complex.    
 
We further show that Tie2:Cre;Brg1F/F AVC cushions express normal levels of 
early EMT transcription factors, such as Twist1, yet are incompetent to downregulate 
endothelial gene expression. Furthermore, Tie2:Cre;Brg1F/F AVCs retained beta-catenin 
expression at the cell membrane in transforming endocardial cells, as well as failed to 
repress endocardial marker, Nfatc1. A transcription factor expressed only in completely 
transformed mesenchymal cells, Sox9, appears downregulated in E9.75 Brg1-mutant 
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AVC cushions. We hypothesize that Sox9 is directly regulated by the BAF complex and 
loss of Brg1 hinders Sox9 activation, thus fostering an intermediate EMT phenotype, 
which ultimately leads to programmed apoptosis.  
 
In conclusion, my data has shown a requirement for Brg1 to generate EMT-
derived mesenchyme for proper semilunar valve maturation. From the findings presented 
in Chapter II, we found that the myxomatous valve phenotype observed in 
Nfatc1Cre;Brg1F/F mice was due to a compensation mechanism of the cardiac neural crest 
mesenchyme. Moreover, my work in Chapter II characterizes the bicuspid aortic valve 
(BAV) defects that resulted from the semilunar valve defect progressing towards the 
diseased state. The data in Chapter III illustrates the requirement for Brg1 in the EMT 
process and attempts to identify where the BAF complex interfaces within the activation 
cascade of EMT.  
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APPENDIX 
 
SUPPLEMENTAL MATERIAL (CHAPTER II) 
 
SUPPLEMENTAL FIGURES 
 
 
 
 
 
 
  
Figure S1. Schematic of semilunar valve anatomy.  
(A) Frontal cross-sectional view of a semilunar valve. Each of the three cusps extends from 
the underlying muscle to form a bisected hemi-cup-like structure enclosing an aortic sinus on 
the arterial side. Each cusp has a flexible distal cusp (purple) and a stiffer base-region (basal 
cusp, green) where the cusp meets the adjacent myocardium/smooth muscle. The basal cusp, 
which has a distinct extracellular matrix composition, begins approximately where the cusp 
angle shifts from being largely parallel to perpendicular with the underlying muscle. The 
junction between the distal and basal cusp appears as a narrowing in sectional views and is 
sometimes called the “hinge”. (B) A splayed or open view of the aortic valve showing the 3-D 
organization of the distal and basal regions of the three cusps. The basal cusp region extends 
along the entire muscle-attached edge of the cusp. The distal cusp extends from the base to the 
free edge. (C) Transverse section aortic valve schematic. Base-regions of the aortic and 
pulmonic valves are enriched with Tenascin C (green), whereas Versican and Periostin 
predominantly localize within the distal cusp regions (purple). AoV: aortic valve; LCC: left-
coronary cusp; NCC: non-coronary cusp; RCC: right-coronary cusp; S.M.: smooth muscle; 
Tnc: Tenascin C; Postn: Periostin; Vcan, Versican.  	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Figure S2. Nfatc1Cre;Brg1F/F mice have congenital heart abnormalities.  
(A) Mouse mating scheme used to conditionally delete floxed Brg1 alleles in endocardial cells 
using Nfatc1Cre. (B-E) Hematoxylin and eosin (H&E) stained sections of hearts from P0 
wildtype and Nfatc1Cre;Brg1F/F mice. Endocardial Brg1-deficient mice have a thickened 
ventricular myocardium containing dilated coronary veins (black arrowheads), indicative of 
coronary artery disease. (F) Observed versus expected frequency of mice of genotype 
Nfatc1Cre;Brg1F/F  harvested at indicated developmental stages from genetic crosses outlined in 
(A). Endocardial Brg1-deficient mice die between late embryonic development and birth 
producing few viable Nfatc1Cre;Brg1F/F mice at weaning age and beyond. (G-J) Widefield 
fluorescence images of anti-Pecam (red) and anti-GFP (green, Nfatc1:Cre-lineage cells 
marked using R26RmTmG transgene) antibody stained heart sections from E16.5 control and 
Nfatc1Cre;Brg1F/F mice. Nuclei are stained with Hoechst (blue). (I, J) Gray scale images 
showing the Nfatc1Cre lineage labeling alone from (G, H) respectively. Wildtype embryos 
form lineage-labeled endocardial-derived coronary arteries in the left ventricle myocardium 
(white arrowheads).  The reduced coronary artery network in Nfatc1Cre;Brg1F/F mice (yellow 
arrowheads) reflects a decrease of endocardial-origin coronary artery endothelium. Coronary 
artery defects may contribute to the perinatal lethality of endocardial Brg1-deficient mice. (K-
P) H&E stained sections showing indicated valves of P0 wildtype and viable Nfatc1Cre;Brg1F/F 
mice. Endocardial Brg1-deficient mice have thickened and poorly organized pulmonic (L) and 
aortic (N) valves. (O, P) Mitral valves are unaffected. P0: postnatal day 0; AC: anterior cusp; 
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Figure S3. Semilunar valve defects in Nfatc1Cre;Brg1F/F embryos first manifest at E14.5.  
(A-H) Hematoxylin and eosin (H&E) stained paraffin sections through pulmonic valves (PV) 
of wildtype and Nfatc1Cre;Brg1F/F embryos (transverse oriented) at indicated embryonic 
stages. PV defects in Nfatc1Cre;Brg1F/F embryos are first apparent at E14.5, when the PV is 
qualitatively shorter (less elongated) and lacks the distinct distal and base/hinge regions of 
wildtype littermate embryos. The phenotype progressively becomes more dramatic, with the 
PVs from E16.5 Nfatc1Cre;Brg1F/F embryos also appearing larger in a sectional view. (I) 
Morphometric analyses of E14.5 wildtype and Nfatc1Cre;Brg1F/F PVs. Endocardial Brg1-
deficient PVs have a significantly decreased length:width (29% mean reduction) but no 
change in sectional area or total number of mesenchymal cells / section. Each graph point 
represents one valve, with values normalized to the mean of littermate wildtype embryos 
(n=8). The asterisk indicates a significant difference between groups (P value calculated by 
two-tailed Student’s t-test). (J-M) H&E sectioned E14.5 (J, K) or E16.5 (L, M) hearts showing 
the ventricular septum of wildtype and Nfatc1Cre;Brg1F/F embryos. Endocardial Brg1-deficient 
embryos frequently show a membranous ventricular septal defect (arrows in K) at E14.5, 
which almost always resolves by E16.5 in surviving embryos. NS: not significant; L/W: 
length-to-width; RV: right ventricle; LV: left ventricle. Scale bars: 100 µm. 	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Figure S4. Nfatc1:cre-mediated deletion of endocardial-lineage Brg1 protein at E14.5. 
(A-F) Widefield fluorescence images of E14.5 embryo sections through indicated cardiac 
valves immunostained for Brg1 protein (gray) with Hoechst-stained nuclei in purple. (A-C) 
Brg1 is normally expressed in all endocardial cells and mesenchymal cells of the pulmonic, 
aortic, and mitral valves. (D-F) Nfatc1Cre;Brg1F/F cardiac valves at E14.5. (D, E) Brg1 
expression is lost in all endocardial cells of the semilunar valves (white arrowheads) and some 
mesenchymal cells concentrated at the base of the valve cusps (yellow arrowheads). (F) The 
atrioventricular canal-derived mitral valve exhibits a more substantial but still partial loss of 
Brg1 in valve mesenchyme (white arrowhead). As with the semilunar valves, Brg1 is largely 
removed from endocardial cells (white arrowhead).  Scale bars: 100 µm. 	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Figure S5. 3-D reconstructed valves show the variability of semilunar valve defects in 
endocardial-lineage Brg1-deficient embryos. 
3-dimensional renderings of E16.5 wildtype and Nfatc1Cre;Brg1F/F and wildtype aortic valves 
reconstructed using serial hematoxylin and eosin (H&E) stained paraffin tissue sections. (A-
D) View from the muscle wall-side (muscle hidden, arterial side up) of the left coronary cusps 
of E16.5 wildtype and Nfatc1Cre;Brg1F/F embryos. Sections from the same embryos are shown 
in (C, D). Both views show the greatly reduced aortic sinus in endocardial Brg1-deficient 
embryos. The aortic channel is narrowed but not occluded. (E, F) Nfatc1Cre;Brg1F/F E16.5 
embryos retain coronary artery ostia. (G-Q) Arterial-side views of 3-D rendered E16.5 aortic 
valves of wildtype and Nfatc1Cre;Brg1F/F embryos. Reconstructed valves from embryos 
representing four litters, as denoted, are shown. “W” and “M” represent “wildtype” and/or 
Nfatc1Cre;Brg1F/F “mutant”, respectively. (R) Volume measurements from 3-D rendered aortic 
valves. There is no significant increase in total aortic valve volume in Nfatc1Cre;Brg1F/F 
embryos. AoV: aortic valve; LCC (blue): left coronary cusp; NCC (red): non-coronary cusp; 
RCC (yellow): right coronary cusp; LCC-NCC (purple): bicuspid fusion between left and non-
coronary cusps; WX.X, wildtype embryo; MX.X, Nfatc1Cre;Brg1F/F embryo; first number (X.X) 
represents litter and second number (X.X) refers to embryo identifier; NS, not statistically 
significant. Scale bars: 100 µm. 	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Figure S6. Pulmonic valves of endocardial Brg1-deficient embryos exhibit no change in 
overall mesenchymal cell proliferation or programmed cell death. 
(A-D) Proliferation assays on pulmonic valve (PV) paraffin sections by 5-ethynyl-2’-
deoxyuridine (EdU) incorporation detected using Click-iT reagents (cyan). Nuclei are 
Hoechst-stained and shown in purple. EdU was injected into pregnant females two hours prior 
to embryo harvesting. Nfatc1Cre;Brg1F/F embryos exhibit unchanged overall PV mesenchyme 
proliferation at E14.5 or E15.5, as quantified in (I). (E, F) Terminal deoxynucleotidyl 
transferase dUTP nick end labeling (TUNEL) staining on paraffin sections of wildtype and 
Nfatc1Cre;Brg1F/F pulmonic valves at E15.5. Only rare and dispersed TUNEL+ apoptotic cells 
(green, ~1% of cells, see (K)) are found in both wildtype and Nfatc1Cre;Brg1F/F semilunar 
valves. (G, H) Immunostaining for an additional cell death marker, cleaved caspase 3 (green), 
further shows the normal and sparse amount of apoptosis in Nfatc1Cre;Brg1F/F  PVs. (I-K) Bar 
graphs of the normalized percentage of EdU+ (I), phospho-histone H3+ (K), and TUNEL+ (L) 
mesenchymal cells in E14.5/E15.5/E16.5 (as indicated) wildtype and Nfatc1Cre;Brg1F/F  PVs. 
Data is normalized to the mean of wildtype samples within each litter. The absolute mean 
percentage of positive cells is shown within each bar. (J) Phospho-histone H3 immunostaining 
at E14.5 and E16.5 shows no statistically significant change in the number of mitotic 
mesenchymal cells in Nfatc1Cre;Brg1F/F  PVs. NS: not significant; PH3+: phosopho-histone 
H3. Scale bars: 100 µm. 	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Figure S7. Nfatc1Crw-PGK;Brg1F/F adult mice show a thickened myocardium and 
myxomatous but not calcified pulmonic valves.  
(A-D) Hematoxylin and eosin (H&E) stained adult heart sections from wildtype and NfatcCre-
PGK;Brg1F/F littermates that highlight the outer walls of the right and left ventricles. The 
dashed line indicates wall thickness. The right and left ventricles of Nfatc1Cre-PGK;Brg1F/F mice 
have a thickened myocardium. (E-H) Von Kossa stained heart sections containing the 
pulmonic or mitral valve of 1 year old (1 yo) wildtype or Nfatc1Cre-PGK;Brg1F/F mice. (E, G) 
Endocardial Brg1-deficient hearts have thickened and extensively Alcian blue-positive PV 
cusps (black arrowheads) that, however, do not become calcified. (F, H) Conversely, 
Nfatc1Cre-PGK;Brg1F/F mitral valves are qualitatively normal. These observations are consistent 
with the embryonic data using the related but more effective Nfatc1Cre line to delete Brg1. RV, 
right ventricle; LV, left ventricle. Scale bars: 100 µm.	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Figure S8. Nfatc1Cre activity in endocardial cells precedes the onset of EMT in both 
outflow tract and atrioventricular canal cushions. 
(A-H) Widefield immunofluorescence images of E9.5 hearts stained for Nfatc1 protein 
(endocardial cells, red) and GFP (Nfatc1:Cre-lineage labeled nuclei, green).  Nuclear lineage 
labeling is provided by the combination of Cre-dependent expression of the reverse 
tetracycline transactivator (rtTA) using the R26RrtTA line, a tetracycline-responsive TRE:H2B-
GFP line, and treating pregnant mice with doxycycline (25 mg/kg IP-injected and 100 µg/ml 
in drinking water) 24 hours prior to harvesting embryos. Both the outflow tract (OFT; A, B, E, 
F) and atrioventricular canal (AVC; C, D, G, H) are shown. (A-D) Nfatc1 protein is expressed 
in all endocardial cells by E9.5. Nfatc1Cre activity partially lags, driving incomplete H2B-GFP 
expression in endocardial cells of the E9.5 OFT (A, B) and more extensive but still partial 
expression in AVC cushion endocardium (C, D). Resultantly, the majority of EMT-derived 
mesenchyme is labeled in the AVC cushion. EMT has only just initiated in the proximal OFT 
so few mesenchymal cells are observed. However, the overlap of Nfatc1 and Nfatc1:Cre-
lineage labeling in the pOFT endocardium does indicate Nfatc1Cre is capable of driving target 
gene recombination in many endocardial cells prior to pOFT EMT onset. (E-H) 
Nfatc1Cre;Brg1F/F embryos show similar patterns of Nfatc1 protein and Nfatc1Cre activation 
within the OFT and AVC. The persistence of lineage-labeled AVC mesenchyme in 
Nfatc1Cre;Brg1F/F embryos shows how Nfatc1Cre-promoted Brg1 protein loss-of-function is 
delayed, allowing EMT to complete even while the otherwise essential Brg1 gene is in the 
process of being recombined into a null allele. White and red arrowheads show GFP-positive 
and negative endocardial cells, respectively. V: ventricular chamber. Scale bars: 100 µm.	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Figure S9. Partial loss of endocardial Brg1 in the E10.5 proximal outflow tract and 
atrioventricular canal following Nfatc1Cre-mediated recombination. 
 (A-L) Paraffin sections of E10.5 wildtype and Nfatc1Cre;Brg1F/F  outflow tract (OFT) and 
atrioventricular canal (AVC) cushions immunostained for Brg1 (red/grayscale) and Nfatc1 
(green/grayscale). Hoechst-stained nuclei are in blue. Channels are separated and in gray scale 
in the panels showing magnified regions (marked by dashed boxes). (A-F) Brg1 protein is 
expressed in all endocardial and mesenchymal cells of wildtype proximal OFT (pOFT), distal 
OFT (dOFT) and AVC cushions at E10.5. (G, H) Approximately half of Nfatc1Cre;Brg1F/F  
pOFT endocardial (55%) and mesenchymal (47%) cells lose detectable Brg1 protein by E10.5. 
(I, J) A higher percentage of Nfatc1Cre;Brg1F/F  dOFT endocardial (85.1%) and mesenchymal 
(78.9%) cells retain Brg1. This difference is likely because dOFT endocardial cells have been 
more recently established from non-Nfatc1 expressing progenitor cells and much of the dOFT 
mesenchyme is not EMT-derived. (K-M) Mirroring the OFT, 50.7% of endocardial cells and 
51% of mesenchymal cells in E10.5 Nfatc1Cre;Brg1F/F AVC cushions remained Brg1-
expressing. (M) Bar graph displaying the normalized percentage of endocardial cells and 
mesenchymal cells retaining Brg1 protein in wildtype (control) and Nfatc1Cre;Brg1F/F pOFT, 
dOFT, and AVC cardiac cushions. Error bars show one standard deviation from the mean. Red 
arrowheads mark Brg1-deleted cells. White arrowheads denote Brg1-retaining cells. Endo.: 
endocardium; mes.: mesenchyme. Scale bars: 100 µm.	  
	   66 
 
 
  
Figure S10. Brg1 deletion in non-EMT programmed valve endocardial cells does not 
result in semilunar valve defects.  
(A-D) Lineage tracing by immunostaining for GFP (green) on pulmonic (A, B) or mitral valve 
(C, D) sections of E13.5 wildtype (Nfatc1enh:Cre;Brg1F/+;R26RmTmG) and Brg1-deficient 
(Nfatc1enh:Cre;Brg1F/F;R26RmTmG) embryos. Hoechst-stained nuclei are in purple. White 
arrowheads indicate endocardial cells. As expected, the Nfatc1enh:Cre line promotes  
recombination exclusively in valve endocardium and not cushion mesenchyme. The Cre 
reporter pattern is unchanged in Nfatc1enh:Cre;Brg1F/F embryos. (E-L) H&E stained paraffin 
tissue sections from wildtype and Nfatc1enh:Cre;Brg1F/F at E14.5 (E-H) and E16.5 (I-L). 
Black arrowheads show the base/hinge region of pulmonic valves. Both the pulmonic and 
mitral valves of Nfatc1enh:Cre;Brg1F/F embryos are indistinguishable from those of control 
littermates at all stages. Scale bars: 100 µm. 	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Figure S11. Known semilunar valve disease promoting genes are expressed normally in 
Nfatc1Cre;Brg1F/F embryos. 
A bar graph of a quantitative RT-PCR study comparing the expression of indicated genes 
between control and Nfatc1Cre;Brg1F/F  dissected E14.5 heart valve regions. Genes were 
selected based on mouse model studies connecting them with semilunar valve defects. These 
studies include germline null mutations (Adamts5KO, Cx43KO, Hb-egfKO, PlceKO, PtpnllKO/+, 
Tgfb2KO) or cell type-specific targeted alleles (Tie2:Cre (endocardial cells) targeted deletion of 
Bmprll and Cxcr7; Nkx2.5:Cre (second heart field) deletion of Frs2a) that produce thickened, 
myxomatous, and/or bicuspid valves  (Ya et al. 1998; Iwamoto et al. 2003; Jackson et al. 
2003; Tadano et al. 2005; Zhang et al. 2010; Azhar et al. 2011; Dupuis et al. 2011). Gata5 and 
Ptpn11 have both loss of function mouse models that result in semilunar valve defects and are 
genetically linked to human valve disease (Chen et al. 2000; Laforest et al. 2011; Lauriol and 
Kontaridis 2011; Padang et al. 2012). Fold changes are normalized to the mean of wildtype 
samples within each litter to allow combining data. Black and gray error bars show one 
standard deviation for Nfatc1Cre;Brg1F/F and wildtype samples, respectively. Two-tailed 
Student’s t-tests using ΔCTs identified no significantly misexpressed transcripts. 
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Figure S12. Novel SLV-expressed genes identified by whole transcriptome sequencing 
show specific and unique expression patterns in developing hearts.  
Additional in situ hybridizations to those shown in Fig. 7 for the indicated transcripts on 
frozen sections (except A-D, which are paraffin) from E13.5 wildtype and Nfatc1Cre;Brg1F/F 
embryos. Aortic valves (AV), mitral valves (MV), right ventricle (RV, G, J), or pulmonic 
artery (PA) are shown, as noted. (A-D) Nptx1 expression is increased in Nfatc1Cre;Brg1F/F 
embryos but retains its normal pattern concentrated in distal endocardial cells of the AV. 
Nptx1 has little to no expression in the MV. (E-J) Cthrc1 is restricted to mesenchyme in the 
base of the AV cusp and/or in muscle surrounding the valve in wildtype embryos. Expression 
levels are increased in AV mesenchyme in endocardial lineage Nfatc1Cre;Brg1F/F embryos. In 
the MV of wildtype embryos, Cthrc1 is concentrated in arterial-side mesenchyme at the leaflet 
base. Nfatc1Cre;Brg1F/F embryos have expanded and increased Cthrc1 levels in MV 
mesenchyme. Cthrc1 is ectopically expressed in ventricular endocardium of Nfatc1Cre;Brg1F/F 
embryos. (K-N) Enpp2 is specific to a subset of endocardial cells adjacent to the base-region 
of the wildtype AV. Enpp2 AV expression is decreased in Nfatc1Cre;Brg1F/F embryos. 
Endocardial expression of Enpp2 on the ventricular side of the parietal mitral valve leaflet is 
also decreased with endocardial-specific deletion of Brg1. (O-T) Irf6 is expressed in aortic 
artery endothelium, which extends through the arterial-side endocardium of the aortic valve. 
Irf6 is not detectably expressed on the ventricular side of AV. Nfatc1Cre;Brg1F/F embryos 
exhibit decreased Irf6 in endocardium associated with the AV with no change in artery 
endothelial cells. The mitral valve does not express Irf6 in wildtype or Nfatc1Cre;Brg1F/F 
embryos and PA endothelial Irf6 is unchanged in Nfatc1Cre;Brg1F/F embryos. For all panels, 
black and red arrowheads show sites of normal or misexpressed/mislocalized transcript 
expression, respectively. Scale bars: 100 µm.	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Figure S13. Schematic summary of semilunar valve disease-like phenotypes observed in 
endocardial Brg1-deficient mice. 
(A, B) Frontal and transverse schematics depicting the semilunar valve disease-like phenotypes in 
Nfatc1Cre;Brg1F/F mice compared to the wildtype state. Semilunar valves (SLVs) of 
Nfatc1Cre;Brg1F/F embryos and surviving adults have shortened or lost sinuses (black arrowheads). 
The SLV cusps have reduced or absent Tenascin (Tnc) rich base-regions (white arrowheads), 
particularly in the left cusps of both the aortic and pulmonic valves. This defect originates from a 
deficiency of endocardial-to-mesenchymal transformation (EMT)-derived mesenchyme that 
reflects a requirement for Brg1 in the initial EMT process. Mesenchyme of other origins 
(presumably, cardiac neural crest cells) that normally concentrates in the distal cusp expands to 
replace the lost base-region mesenchyme. Effectively, the cusps become of entirely “distal cusp 
identity”, unable to form a fully patterned SLV. The SLV defects progress to a myxomatous state 
that includes the presence of cartilaginous nodules in the atypical base-regions (white arrows) and 
increased/disorganized Postn throughout the cusps (black arrows). Additionally, endocardial Brg1-
deficient embryos frequently have fused semilunar valve cusps. When bicuspid, the aortic valve 
most commonly exhibits a LCC-NCC cusp fusion arrangement. Coronary ostia remain present in 
Nfatc1Cre;Brg1F/F mice. Tnc: Tenascin C; Postn: Periostin; LCC: left coronary cusp; NCC: non-
coronary cusp; RCC: right coronary cusp.  	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SUPPLEMENTAL MATERIAL AND METHODS 
Transgenic Mice 
Nfatc1Cre,  Nfatc1Cre-PGK, and Nfatc1enh:Cre mice were provided by Dr. Bin Zhou (Wu et 
al. 2011; 2012). Brg1-floxed allele mice originate from Dr. Pierre Chambon’s laboratory 
(Sumi-Ichinose et al. 1997). R26RmTmG (Muzumdar et al. 2007), R26RrtTA (Belteki et al. 
2005), Tie2:Cre (Kisanuki et al. 2001), and TRE:H2B-GFP (Tumbar et al. 2004) mice 
were acquired from the Jackson Laboratory. 
 
qRT-PCR primer sequences  
Hprt 5’ GCTGGTGAAAAGGACCTCT 3’, 5’ CACAGGACTAGAACACCTGC 3’ 
(Stankunas et al. 2008); Cx40 5’ AGTTGAACAGCAGCCAGAGC 3’, 5’ GACTGTGG-
AGTGCTTGTGGA 3’; Cxcr7 5’ GGTCAGTCTCGTGCAGCATA 3’, 5’ GTGCGGTG-
AAGTAGGTGAT 3’ (Sierro et al. 2007); PLCe 5’ TCAGTGCCTGGAGCAGCAG 3’, 
5’ CTTGAAGGGGATCTTGGTTG 3’ (Tadano et al. 2005); Hb-egf 5’ AGGTGTCATG-
GGCTGACTCT 3’, 5’ CACGCCCAACTTCACTTTCT 3’; Nfatc1 5’ AGTTATGGCC- 
AGACAGCACCATCT 3’, 5’ TGTGCAGCTACACGGTTACTTGGA 3’ (Stankunas et 
al. 2008); Adamts5 5’ GCTGCTGGTAGCATCGTTACTG 3’, 5’ GAGTGTAGCGC-
GCATGCTT 3’ (Wang et al. 2009); Bmprll 5’ GAAACGATAATCATTGTTTGGC 3’, 
5’ CCCTGTTTCCGGTCTCCTGT3’ (Yu et al. 2005); TgfB2 5’ CTGTACCTTCGTGC- 
CGTCTAATAA 3’, 5’ TGCCATCAATACCTGCAAATCT 3’ (Wang et al. 2009); 
Frs2a 5’ CAGTCGGTGAAGAGTCCACA 3’, 5’ GGGGTTACTCGGCTCTTCTT 3’; 
Gata5 5’ ACATGAGTTCCGACGTAGCC 3’, 5’ CGCAGGCATTGCATAGATAG 3’ 
(Flagg et al. 2007); Ptpn11 5’ GGGCAGCTGAAAGAGAAGAA 3’, 5’ TCTCTCGAA- 
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CGAGGAAGCTG 3’; Cx43 5’ GCCGGCTTCACTTTCATTA 3’, 5’ GCCACCTCTCA- 
TCTTCACCT 3’ (Kumai et al. 2000); Enpp2 5’ GCCTCCATTTGAAAACATTGA 3’, 
5’ TTGTGCGTAGCAGGTGATTC 3’; Col23a1 5’ GTCCCAAAGGACCAAAAGGA 
3’, 5’ CAGGCTCTCTTGTAGATGGTCA 3’; Cthrc1 5’ GACCAAGGAAGCCCTGAG-
TT 3’, 5’ ACCCAGATGGCCACATCTAC 3’; Nptx1 5’ AGGGTGGCAATGGAGAGA-
AC 3’, 5’ GGTCCCAGATGTTGAAATGG 3’; Clec7a 5’ GGAAATTCCTGGTATGG-
AGT 3’, 5’ CATGGCCCTTCACTCTGATT 3’; Smoc1 5’ ACACTGTCCCAGGACTC-
AGC 3’, 5’ CACTCTGGGACAAACACAGC 3’; Irf6 F: 5’ GCACCCATTCAACCCTT-
CTA 3’, 5’ GGGTTGCTCACCGTCATAGT 3’ 
 
Fluorescent immunostaining 
Paraffin sections were deparaffinized with xylenes for 10’ and tissue was rehydrated by 3’ 
sequential washes with a graded ethanol series (100%, 95%, 70%, 50%, 25%) to distilled 
water. Antigens were retrieved by pressure-cooking slides for 10’ in 1X DAKO antigen 
retrieval solution (DAKO) (for Brg1, Cleaved Caspase 3, GFP, PH3, and Versican 
antibodies). A 5’ incubation in 0.25% Trypsin solution (Life Technologies) was used for 
antigen retrieval for double Pecam1 and GFP antibody staining. Primary antibodies used 
were: Brg1 (1:100, SCBT), Cleaved Caspase 3 (1:250, Cell Signaling Technologies), 
GFP (1:250, Aves), Nfatc1 (1:250, Abcam), Pecam1 (1:100, BD Biosciences), PH3 
(1:250, Millipore), Versican (1:250, Millipore). Frozen sections (16 mm, University of 
Oregon histology facility) were used for GFP (1:500, Aves), Periostin (1:100, SCBT), 
and Tenascin C (1:100, US Biological) antibody staining without antigen retrieval. 
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Alexa-conjugated fluorescent secondary antibodies (Life Technologies) were used at 
1:500.  
 
TUNEL staining 
Apoptosis was assayed using the Roche ‘In situ cell death detection kit’. Rehydrated 
paraffin sections were proteinase K (20 mg/ml) treated in 10 mM Tris pH 7.5 at room 
temperature. Slides were sequentially washed twice with 100 mM glycine and PBS. The 
TUNEL reaction was performed at 37°C for one hour. Subsequently, sectioned tissue was 
washed thoroughly with PBS, Hoechst stained, and coverslip-mounted for imaging and 
quantification.  
 
RNA probe synthesis 
In situ probes were synthesized from PCRII-based (Life Technologies) template plasmids 
containing PCR-cloned cDNA fragments. The following primers were used to amplify 
PCR products from embryonic mouse cDNA. Enpp2 5' 
TCCAAAGGGTCTTGGTGAAG 3', 5' CGCAGATGAATGCACCTTTA 3'; Irf6 5' 
GACCCAGGGCTCTGTCATTA 3', 5' CTGTCAAAGGACCGGGTAAA 3'; Cthrc1 5' 
ATGTGTCTACAAGGACCAGCAG 3', 5' ATGGCATTCCAATATATAGGCTTAAAA 
3'; Nptx1 5' GATGGCACCACCTACCAATC 3', 5' AACCTGCTCCTGTTGAGGAA 3'. 
PCRII plasmids were digested with BamHI or NotI to linearize plasmid for digoxigenin-
11-dUTP (DIG) (Roche) labeled RNA synthesis using Sp6/T7 RNA polymerases (Fisher 
Scientific). Synthesized DIG-labeled probes were DNAse treated and LiCl precipitated. 
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RNA was resuspended in RNase/DNase free water and 1-2 ml was used per slide for each 
in situ hybridization assay. 
 
Illumina RNA sequencing and bioinformatics 
RNA sequencing was performed using RNA isolated from E14.5 dissected heart valve 
regions from wildtype and Nfatc1Cre;Brg1F/F embryos. 0.5-1.0 mg of total RNA was 
subjected to Ribo-Zero magnetic bead rRNA-depletion (Epicentre). The rRNA-depleted 
samples were used to generate index-specific Illumina libraries using the ScriptSeq v2 
RNA-seq Library kit following the manufacturer’s protocol (Epicentre). Agencourt 
AMPure magnetic beads (Beckman Coulter) were used for nucleic acid purifications at 
all necessary steps. Illumina sequencing was performed at the University of Oregon 
Genomics and Cell Characterization facility. Raw fastq files are deposited at the NCBI 
Gene Expression Omnibus. 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=czerwoqixfenxul&acc=GSE6778
6).  
 
All computational analysis was performed using the ACISS computing cluster at the 
University of Oregon (http://aciss.uoregon.edu). Reads were quality checked with 
FASTX-Toolkit (http://hannonlab.cshl.edu/fastx_toolkit/) and low-quality reads were 
discarded. Reads were aligned to the Mus musculus reference genome (mm10) with 
Bowtie2 (Langmead and Salzberg 2012), SAMtools (Li et al. 2009), and TopHat2 
(Roberts et al. 2012). For all four samples (two pairs of E14.5 dissected heart valve 
regions from one wildtype and one littermate Nfatc1Cre;Brg1F/F embryo), over 60 million 
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reads were recovered. TopHat 2 aligned reads output (mapped reads/accepted hits files) 
was used to generate a counts table with HTSeq (Anders et al. 2014). Differential 
expression between wildtype and Nfatc1Cre;Brg1F/F tissue was determined with edgeR 
using a paired-sample repeats matrix design (Robinson et al. 2009). From the 43 
differentially expressed genes (DEGs), we highlighted 26 genes based on their expression 
in E14.5 hearts (Eurexpress atlas, (Diez-Roux et al. 2011) and/or literature linking them 
to morphogenesis, cell signaling, or gene regulation. We disregarded any of these DEGs 
that showed ubiquitous expression or were hematopoietic lineage-enriched transcripts 
that could represent blood pooling or secondary inflammatory responses in 
Nfatc1Cre;Brg1F/F embryos.  The remaining seven most up- or down- regulated genes 
were selected for further study using qRT-PCR and RNA in situ hybridization. 
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